- Medical School - , Medicine
![Martin Pomper, M.D., Ph.D.](https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/original_images/Martin-Pomper-800x800.png)
Martin Pomper, M.D., Ph.D.
- Effie and Wofford Cain Distinguished Chair in Diagnostic Imaging
- Radiology - Emergency Department
Biography
Martin G. Pomper, M.D., Ph.D., is a Professor and Chair of Radiology at UT Southwestern Medical Center and serves in both the Neuroradiology and Nuclear Medicine Divisions. He holds the Effie and Wofford Cain Distinguished Chair of Diagnostic Imaging.
Originally from Chicago, Illinois, Dr. Pomper received both his Ph.D. and M.D. degrees from the University of Illinois at Urbana-Champaign. He then underwent an internship on the Osler Medical Service, residency training in diagnostic radiology and separately in nuclear medicine, followed by a fellowship in neuroradiology, at Johns Hopkins University in Baltimore, Maryland.
Before joining UT Southwestern in 2023, Dr. Pomper served on the faculty of the Russell H. Morgan Department of Radiology and Radiological Science at Johns Hopkins University as the Director of the Division of Nuclear Medicine. He was the inaugural William R. Brody Chair of Radiology and later the Henry N. Wagner, Jr., M.D. Chair of Nuclear Medicine. He also served as the Associate Dean for Entrepreneurship and Technology Development and held joint appointments in several schools and departments including the Department of Pharmacology and Molecular Sciences, the Sidney Kimmel Comprehensive Cancer Center, and the Department of Biomedical Engineering.
Dr. Pomper focuses his research on molecular imaging and therapy for cancer and central nervous system disorders. His work has resulted in nearly 500 peer-reviewed publications in scientific journals and a number of patents and presentations at professional conferences throughout the world.
While his work has involved molecular-genetic imaging, nanomedicine, and generation of new positron emission tomography (PET)-based agents for neuroinflammation, his greatest effort has been in the discovery and development of small molecules targeting the prostate-specific membrane antigen (PSMA). He created the first small molecules for imaging PSMA and the first commercial PSMA-targeted PET agent (PYLARIFY®). His group also created the first PSMA-targeted imaging and therapeutic (theranostic) agents incorporating a radiometal. Compounds of the same chemical class have been approved by the FDA and are used worldwide to help manage patients with prostate cancer.
Dr. Pomper’s commitment to advancing medical research is evidenced by his service to the Board of Scientific Counselors of the National Institutes of Health, the Scientific Review Committee of the Cancer Prevention and Research Institute of Texas, the Society of Nuclear Medicine and Molecular Imaging, and the World Molecular Imaging Society.
During his spare time, Dr. Pomper enjoys spending time with family, reading, music, and sports.
Education & Training
Books & Publications
-
Publications
-
Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer
Sutera P, Deek MP, Deek RA, Guler OC, Hurmuz P, Reyhan M, Rowe S, Radwan N, Dipasquale S, Hrinivich WT, Lowe K, Ren L, Saraiya B, Ennis R, Hathout L, Mayer T, Deweese TL, Song DY, Kiess A, Oymak E, Pienta K, Feng F, Pomper M, Ozyigit G, Tran PT, Onal C, Phillips RM Advances in Radiation Oncology 2024 Jul 9 -
A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation
Feng Y, Meshaw RL, Finch SW, Zheng Y, Minn I, Vaidyanathan G, Pomper MG, Zalutsky MR Nuclear Medicine and Biology 2024 Jul 134-135 -
PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy
Oldan JD, Almaguel F, Voter AF, Duran A, Gafita A, Pomper MG, Hope TA, Rowe SP Cancer Journal 2024 May 30 176-184 -
Reply to Madhur Anand, Bela Jain, and Swati Aggarwal's Letter to the Editor re: Rudolf A. Werner, Philipp E. Hartrampf, Wolfgang P. Fendler, et al. Prostate-Specific Membrane Antigen Reporting and Data System Version 2.0. Eur Urol 2023;84:491–502
Hartrampf PE, Rowe SP, Pomper MG, Higuchi T, Gorin MA, Werner RA European urology 2024 May 85 e146-e147 -
Investigating the Mechanism of Aluminum Fluoride Chelation
Carroll L, Holt D, Cha H, Catazaro J, Thorley KJ, Dannals RF, Pomper MG Inorganic Chemistry 2024 May 63 9831-9841 -
Beyond synthetic aperture focusing: deconvolution-based elevation resolution enhancement using simulated point spread function for linear array-based three-dimensional photoacoustic imaging
Tang Y, Lesniak WG, Gao S, Wu Y, Pomper MG, Zhang HK Biomedical Optics Express 2024 Mar 15 1847-1860 -
Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and Prognosis of Cancer on PET/CT
Leung KH, Rowe SP, Sadaghiani MS, Leal JP, Mena E, Choyke PL, Du Y, Pomper MG Journal of Nuclear Medicine 2024 65 643-650 -
Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT
Wang F, Liu C, Vidal I, Mana-Ay M, Voter AF, Solnes LB, Ross AE, Gafita A, Schaeffer EM, Bivalacqua TJ, Pienta KJ, Pomper MG, Lodge MA, Song DY, Oldan JD, Allaf ME, De Marzo AM, Sheikhbahaei S, Gorin MA, Rowe SP Journal of Nuclear Medicine 2024 Jan 65 87-93 -
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging
Voter AF, Werner RA, Savas H, Gafita A, Ross AE, Gorin MA, Solnes LB, Pomper MG, Rowe SP, Sheikhbahaei S Seminars in Nuclear Medicine 2024 Jan 54 119-131 -
The cutting edge: Promising oncology radiotracers in clinical development
Oldan JD, Pomper MG, Werner RA, Higuchi T, Rowe SP Diagnostic and Interventional Imaging 2024 -
Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation
Lesniak WG, Boinapally S, Lofland G, Jiang Z, Foss CA, Azad BB, Jablonska A, Garcia MA, Brzezinski M, Pomper MG International Journal of Nanomedicine 2024 19 4995-5010 -
Standardized PSMA-PET Imaging of Advanced Prostate Cancer
Seifert R, Gafita A, Telli T, Voter A, Herrmann K, Pomper M, Hadaschik B, Rowe SP, Fendler WP Seminars in Nuclear Medicine 2024 Jan 54 60-68 -
Prostate-Specific Membrane Antigen-Ligand Therapy: What the Radiologist Needs to Know
Rowe SP, Sadaghiani MS, Gafita A, Sheikhbahaei S, Pomper MG, Young J, Spitz A, Werner RA, Oldan JD, Solnes LB Radiologic Clinics of North America 2024 Jan 62 177-187 -
Prognostic Performance of RECIP 1.0 Based on [18F]PSMA-1007 PET in Prostate Cancer Patients Treated with [177Lu]Lu-PSMA I&T
Hartrampf PE, Hüttmann T, Seitz AK, Kübler H, Serfling SE, Higuchi T, Schlötelburg W, Michalski K, Gafita A, Rowe SP, Pomper MG, Buck AK, Werner RA Journal of Nuclear Medicine 2024 65 560-565 -
Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer
Sutera P, Song Y, Van der Eecken K, Shetty AC, English K, Hodges T, Chang J, Fonteyne V, Rana Z, Ren L, Mendes AA, Lumen N, Delrue L, Verbeke S, De Man K, Song DY, Pienta K, Feng FY, Joniau S, Lotan T, Lane B, Kiess A, Rowe S, Pomper M, DeWeese T, Deek M, Sweeney C, Ost P, Tran PT European urology 2023 Dec 84 531-535 -
Membrane-derived particles shed by PSMA-positive cells function as pro-angiogenic stimuli in tumors
Machado CM, Skubal M, Haedicke K, Silva FP, Stater EP, Silva TL, Costa ET, Masotti C, Otake AH, Andrade LN, Junqueira Md, Hsu HT, Das S, Larney BM, Pratt EC, Romin Y, Fan N, Manova-Todorova K, Pomper M, Grimm J Journal of Controlled Release 2023 Dec 364 312-325 -
Role of Functional SPECT and PET in Renal Emergencies
Higuchi T, Hartrampf PE, Buck AK, Pomper MG, Rowe SP, Serfling SE, Werner RA Seminars in Nuclear Medicine 2023 Nov 53 786-796 -
Prostate-specific Membrane Antigen Reporting and Data System Version 2.0
Werner RA, Hartrampf PE, Fendler WP, Serfling SE, Derlin T, Higuchi T, Pienta KJ, Gafita A, Hope TA, Pomper MG, Eiber M, Gorin MA, Rowe SP European urology 2023 Nov 84 491-502 -
Non-invasive PD-L1 quantification using [ 18 F]DK222-PET imaging in cancer immunotherapy
Mishra A, Gupta K, Kumar D, Lofland G, Sharma AK, Solnes LB, Rowe SP, Forde PM, Pomper MG, Gabrielson EW, Nimmagadda S Journal for ImmunoTherapy of Cancer 2023 Oct 11 -
Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits
Smith GS, Kuwabara H, Yan H, Nassery N, Yoon M, Kamath V, Kraut M, Gould NF, Savonenko A, Coughlin JM, Lodge M, Pomper MG, Nandi A, Holt D, Dannals RF, Leoutsakos JM Journal of Alzheimer's Disease 2023 Oct 96 215-227 -
[18F]FNDP PET neuroimaging test–retest repeatability and whole-body dosimetry in humans
Du Y, Coughlin JM, Amindarolzarbi A, Sweeney SE, Harrington CK, Brosnan MK, Zandi A, Shinehouse LK, Sanchez AN, Abdallah R, Holt DP, Fan H, Lesniak WG, Nandi A, Rowe SP, Solnes LB, Dannals RF, Horti AG, Lodge MA, Pomper MG European Journal of Nuclear Medicine and Molecular Imaging 2023 Oct 50 3659-3665 -
Test–retest repeatability of organ uptake on PSMA-targeted 18F-DCFPyL PET/CT in patients with prostate cancer
Werner RA, Lütje S, Habacha B, Bundschuh L, Higuchi T, Buck AK, Kosmala A, Lapa C, Essler M, Lodge MA, Pienta KJ, Eisenberger MA, Markowski MC, Gorin MA, Pomper MG, Rowe SP, Bundschuh RA Prostate 2023 Sep 83 1186-1192 -
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer
Alati S, Singh R, Pomper MG, Rowe SP, Banerjee SR Seminars in Nuclear Medicine 2023 Sep 53 663-686 -
SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T
Hartrampf PE, Hüttmann T, Seitz AK, Kübler H, Serfling SE, Schlötelburg W, Michalski K, Rowe SP, Pomper MG, Buck AK, Eberlein U, Werner RA European Journal of Nuclear Medicine and Molecular Imaging 2023 Sep 50 3465-3474 -
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
Duan X, Xia L, Zhang Z, Ren Y, Pomper MG, Rowe SP, Li X, Li N, Zhang N, Zhu H, Yang Z, Sheng X, Yang X Clinical Cancer Research 2023 Sep 29 3395-3407 -
Detection of Biochemically Recurrent Prostate Cancer with [18F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations with Serum Prostate-Specific Antigen Parameters
Sadaghiani MS, Sheikhbahaei S, Al-Zaghal A, Solnes LB, Pomper MG, Oldan JD, Ulaner GA, Gorin MA, Rowe SP Tomography 2023 Aug 9 1504-1514 -
Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics
Boinapally S, Alati S, Jiang Z, Yan Y, Lisok A, Singh R, Lofland G, Minn I, Hobbs RF, Pomper MG, Banerjee SR Molecules 2023 Aug 28 -
Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging
Bonaventura J, Boehm MA, Jedema HP, Solis O, Pignatelli M, Song X, Lu H, Richie CT, Zhang S, Gomez JL, Lam S, Morales M, Gharbawie OA, Pomper MG, Stein EA, Bradberry CW, Michaelides M Science translational medicine 2023 Jul 15 -
First-in-human imaging using [11C]MDTC: a radiotracer targeting the cannabinoid receptor type 2
Du Y, Coughlin JM, Brosnan MK, Chen A, Shinehouse LK, Abdallah R, Lodge MA, Mathews WB, Liu C, Wu Y, Minn I, Finley P, Hall AW, Lesniak WG, Dannals RF, Horti AG, Pomper MG European Journal of Nuclear Medicine and Molecular Imaging 2023 Jul 50 2386-2393 -
Pilot imaging of the colony stimulating factor 1 receptor in the brains of virally-suppressed individuals with HIV
Rubin LH, Du Y, Sweeney SE, O'Toole R, Harrington CK, Jenkins K, Lesniak WG, Veenhuis RT, Dastgheyb R, Severson J, Fan H, Holt DP, Hall AW, Dannals RF, Horti AG, Pomper MG, Coughlin JM AIDS 2023 Jul 37 1419-1424 -
Exploring the potential of the novel imidazole-4,5-dicarboxyamide chemical exchange saturation transfer scaffold for pH and perfusion imaging
Bo S, Stabinska J, Wu Y, Pavuluri KD, Singh A, Mohanta Z, Choudhry R, Kates M, Sedaghat F, Bhujwalla Z, Pomper MG, McMahon MT NMR in biomedicine 2023 Jun 36 -
Lack of repeatability of radiomic features derived from PET scans: Results from a 18F-DCFPyL test–retest cohort
Werner RA, Habacha B, Lütje S, Bundschuh L, Kosmala A, Essler M, Derlin T, Higuchi T, Lapa C, Buck AK, Pienta KJ, Lodge MA, Eisenberger MA, Markowski MC, Pomper MG, Gorin MA, Frey EC, Rowe SP, Bundschuh RA Prostate 2023 May 83 547-554 -
6-O-(2-[18F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([18F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo
Levinstein MR, Ventriglia EN, Gomez JL, Budinich RC, Marton J, Henriksen G, Holt DP, Dannals RF, Pomper MG, Zarate CA, Bonaventura J, Michaelides M Molecular Imaging and Biology 2023 Apr 25 384-390 -
Multi-timepoint imaging with PSMA-targeted [18F]F-Florastamin PET/CT: lesion detection and comparison to conventional imaging
Sheikhbahaei S, Bello Martinez R, Markowski MC, Eisenberger MA, Pienta KJ, Reyes D, Brosnan MK, Spiro E, AbdAllah R, Holt DP, Dannals RF, Werner RA, Pomper MG, Gorin MA, Solnes LB, Rowe SP Annals of Nuclear Medicine 2023 Apr 37 246-254 -
Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells
Merino VF, Yan Y, Ordonez AA, Bullen CK, Lee A, Saeki H, Ray K, Huang T, Jain SK, Pomper MG Antiviral Research 2023 Mar 211 -
High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data
Bundschuh RA, Lütje S, Bundschuh L, Lapa C, Higuchi T, Hartrampf PE, Gorin MA, Kosmala A, Buck AK, Pomper MG, Rowe SP, Essler M, Sheikh GT, Werner RA Clinical nuclear medicine 2023 Mar 48 207-212 -
Feasibility of Spectra-Based Quantification Algorithm for Non-Linear Photoacoustic Contrast Agents
Serebrennikova L, Gao S, Murakami R, Boinapally S, Ray S, Pomper MG, Zhang HK 2023 -
Fluence Compensation for Linear Array-Based Photoacoustic Imaging System Using Geometrical Depth Mapping
Tang Y, Lesniak WG, Pomper MG, Zhang HK 2023 -
Erratum: Targeted Theranostic 111In/Lu-Nanotexaphyrin for SPECT Imaging and Photodynamic Therapy (Molecular Pharmaceutics (2022) 19:6 (1803−1813) DOI: 10.1021/acs.molpharmaceut.1c00819)
Cheng MH, Overchuk M, Rajora MA, Lou JW, Chen Y, Pomper MG, Chen J, Zheng G Molecular Pharmaceutics 2023 Jan 20 783 -
Image acquisition and interpretation of 18F-DCFPyL (piflufolastat F 18) PET/CT: How we do it
Rowe SP, Voter AF, Werner RA, Zukotynski KA, Pomper MG, Gorin MA, Solnes LB Canadian Journal of Urology 2023 30 11432-11437 -
Imaging Brain Injury in Former National Football League Players
Rubin LH, Du Y, Sweeney SE, O’Toole R, Thomas CL, Zandi AG, Shinehouse LK, Brosnan MK, Nam H, Burke ME, Bureau SC, Kilgore JJ, Yoon M, Soule AR, Lesniak WG, Minn I, Rowe SP, Holt DP, Hall AW, Mathews WB, Smith GS, Nowinski CJ, Kassiou M, Dannals RF, Pomper MG, Coughlin JM JAMA Network Open 2023 E2340580 -
One Hundred Years of the Tracer Principle
Hoberuck S, Zophel K, Pomper MG, Rowe SP, Gafita A Journal of Nuclear Medicine 2023 64 1998-2000 -
Re: “Overcoming Challenges Associated with 18F-DCFPyL PET Imaging in Prostate Cancer”
Rowe SP, Voter AF, Werner RA, Zukotynski KA, Pomper MG, Gorin MA, Solnes LB Canadian Journal of Urology 2023 30 11465-11466 -
PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease
Ismail MS, Peters DE, Rowe SP, Salavati A, Sharma S, Anders RA, Pomper M, Slusher BS, Selaru FM Clinical and Experimental Gastroenterology 2023 16 237-247 -
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Directed Radioligand Therapy
Hartrampf PE, Mihatsch PW, Seitz AK, Solnes LB, Rowe SP, Pomper MG, Kübler H, Bley TA, Bück AK, Werner RA Journal of Nuclear Medicine 2023 64 1272-1278 -
Non-Viral Gene Delivery to Hepatocellular Carcinoma via Intra-Arterial Injection
Vaughan HJ, Zamboni CG, Luly KM, Li L, Gabrielson KL, Hassan LF, Radant NP, Bhardwaj P, Selaru FM, Pomper MG, Green JJ International Journal of Nanomedicine 2023 18 2525-2537 -
Small Molecules as Vectors for Radiopharmaceutical Therapy
Rowe SP, Werner RA, Garg T, Gafita A, Voter AF, Sadaghiani MS, Markowski MC, Paller CJ, Zalutsky MR, Solnes LB, Pomper MG 2023 Jan 349-367 -
The SARS-CoV-2 spike protein binds and modulates estrogen receptors
Solis O, Beccari AR, Iaconis D, Talarico C, Ruiz-Bedoya CA, Nwachukwu JC, Cimini A, Castelli V, Bertini R, Montopoli M, Cocetta V, Borocci S, Prandi IG, Flavahan K, Bahr M, Napiorkowski A, Chillemi G, Ooka M, Yang X, Zhang S, Xia M, Zheng W, Bonaventura J, Pomper MG, Hooper JE, Morales M, Rosenberg AZ, Nettles KW, Jain SK, Allegretti M, Michaelides M Science Advances 2022 Dec 8 -
Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on 18F-DCFPyL PET/CT Scans
Garg T, Werner RA, Chung HW, Khatri W, Pienta KJ, Pomper MG, Gorin MA, Saad E, Rowe SP Tomography 2022 Dec 8 2639-2647 -
Hetero-bivalent agents targeting FAP and PSMA
Boinapally S, Lisok A, Lofland G, Minn I, Yan Y, Jiang Z, Shin MJ, Merino VF, Zheng L, Brayton C, Pomper MG, Banerjee SR European Journal of Nuclear Medicine and Molecular Imaging 2022 Nov 49 4369-4381 -
Correction to: Hetero-bivalent agents targeting FAP and PSMA (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 49, 13, (4369-4381), 10.1007/s00259-022-05933-3)
Boinapally S, Lisok A, Lofland G, Minn I, Yan Y, Jiang Z, Shin MJ, Merino VF, Zheng L, Brayton C, Pomper MG, Banerjee SR European Journal of Nuclear Medicine and Molecular Imaging 2022 Nov 49 4755 -
Photorealistic three-dimensional visualization of fusion datasets: cinematic rendering of PET/CT
Rowe SP, Pomper MG, Leal JP, Schneider R, Krüger S, Chu LC, Fishman EK Abdominal Radiology 2022 Nov 47 3916-3920 -
Automated lesion detection of breast cancer in [18F] FDG PET/CT using a novel AI-Based workflow
Leal JP, Rowe SP, Stearns V, Connolly RM, Vaklavas C, Liu MC, Storniolo AM, Wahl RL, Pomper MG, Solnes LB Frontiers in Oncology 2022 Nov 12 -
18F-Labeled Radiotracers for Prostate-specific Membrane Antigen: Historical Perspective and Future Directions
Rowe SP, Salavati A, Werner RA, Pienta KJ, Gorin MA, Pomper MG, Solnes LB PET Clinics 2022 Oct 17 585-593 -
PET/CT imaging of CSF1R in a mouse model of tuberculosis
Foss CA, Ordonez AA, Naik R, Das D, Hall A, Wu Y, Dannals RF, Jain SK, Pomper MG, Horti AG European Journal of Nuclear Medicine and Molecular Imaging 2022 Oct 49 4088-4096 -
System-level optimization in spectroscopic photoacoustic imaging of prostate cancer
Wu Y, Kang J, Lesniak WG, Lisok A, Zhang HK, Taylor RH, Pomper MG, Boctor EM Photoacoustics 2022 Sep 27 -
Rechallenge with Additional Doses of 177Lu-DOTATOC after Failure of Maintenance Therapy with Cold Somatostatin Analogs
Weich A, Werner RA, Serfling SE, Solnes LB, Pomper MG, Buck AK, Higuchi T, Rowe SP Clinical nuclear medicine 2022 Aug 47 719-720 -
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced Readers
Weich A, Higuchi T, Bundschuh RA, Lapa C, Serfling SE, Rowe SP, Pomper MG, Herrmann K, Buck AK, Derlin T, Werner RA Molecular Imaging and Biology 2022 Aug 24 631-640 -
Generation of Digital Brain Phantom for Machine Learning Application of Dopamine Transporter Radionuclide Imaging
Shao W, Leung KH, Xu J, Coughlin JM, Pomper MG, Du Y Diagnostics 2022 Aug 12 -
PSMA-specific degradable dextran for multiplexed immunotargeted siRNA therapeutics against prostate cancer
Chen Z, Krishnamachary B, Mironchik Y, Ray Banerjee S, Pomper MG, Bhujwalla ZM Nanoscale 2022 Aug 14 14014-14022 -
SPECT and PET Radiotracers in Renal Imaging
Werner RA, Pomper MG, Buck AK, Rowe SP, Higuchi T Seminars in Nuclear Medicine 2022 Jul 52 406-418 -
Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma
Vaughan HJ, Zamboni CG, Hassan LF, Radant NP, Jacob D, Mease RC, Minn I, Tzeng SY, Gabrielson KL, Bhardwaj P, Guo X, Francisco D, Pomper MG, Green JJ Science Advances 2022 Jul 8 -
Molecular imaging in oncology: Current impact and future directions
Rowe SP, Pomper MG CA Cancer Journal for Clinicians 2022 Jul 72 333-352 -
Visualization of Tumor Heterogeneity in Advanced Medullary Thyroid Carcinoma by Dual-Tracer Molecular Imaging: Revealing the Theranostic Potential of SSTR-and PSMA-Directed Endoradiotherapy
Hasenauer N, Higuchi T, Deschler-Baier B, Hartrampf PE, Pomper MG, Rowe SP, Fassnacht M, Buck AK, Werner RA Clinical nuclear medicine 2022 Jul 47 651-652 -
Targeted Theranostic 111In/Lu-Nanotexaphyrin for SPECT Imaging and Photodynamic Therapy
Cheng MH, Overchuk M, Rajora MA, Lou JW, Chen Y, Pomper MG, Chen J, Zheng G Molecular Pharmaceutics 2022 Jun 19 1803-1813 -
DCFPyL PET/CT for Imaging of Prostate Cancer
Rowe SP, Buck A, Bundschuh RA, Lapa C, Serfling SE, Derlin T, Higuchi T, Gorin MA, Pomper MG, Werner RA Nuklearmedizin - NuclearMedicine 2022 Jun 61 240-246 -
Imaging of Cancer Immunotherapy: Response Assessment Methods, Atypical Response Patterns, and Immune-Related Adverse Events, From the AJR Special Series on Imaging of Inflammation
Sheikhbahaei S, Marcus CV, Sadaghiani MS, Rowe SP, Pomper MG, Solnes LB American Journal of Roentgenology 2022 Jun 218 940-952 -
177Lu-PSMA radioligand therapy effectiveness in metastatic castration-resistant prostate cancer: An updated systematic review and meta-analysis
Sadaghiani MS, Sheikhbahaei S, Werner RA, Pienta KJ, Pomper MG, Gorin MA, Solnes LB, Rowe SP Prostate 2022 May 82 826-835 -
First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients
Zhou X, Jiang J, Yang X, Liu T, Ding J, Nimmagadda S, Pomper MG, Zhu H, Zhao J, Yang Z, Li N Journal of Nuclear Medicine 2022 Apr 63 536-542 -
An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications
Lesniak WG, Azad BB, Chatterjee S, Lisok A, Pomper MG Pharmaceutics 2022 Mar 14 -
A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents
Chen Y, Minn I, Rowe SP, Lisok A, Chatterjee S, Brummet M, Banerjee SR, Mease RC, Pomper MG Biomolecules 2022 Mar 12 -
A Unique Core–Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects
Cheng B, Ahn HH, Nam H, Jiang Z, Gao FJ, Minn I, Pomper MG Pharmaceutics 2022 Feb 14 -
68Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent
Duan X, Cao Z, Zhu H, Liu C, Zhang X, Zhang J, Ren Y, Liu F, Cai X, Guo X, Xi Z, Pomper MG, Yang Z, Fan Y, Yang X European Journal of Nuclear Medicine and Molecular Imaging 2022 Feb 49 1030-1040 -
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Dong L, Su Y, Zhu Y, Markowski MC, Xin M, Gorin MA, Dong B, Pan J, Pomper MG, Liu J, Pienta KJ, Xue W, Rowe SP Journal of Nuclear Medicine 2022 Feb 63 248-252 -
An Improved 211At-Labeled Agent for PSMA-Targeted a-Therapy
Mease RC, Kang CM, Kumar V, Banerjee SR, Minn I, Brummet M, Gabrielson KL, Feng Y, Park A, Kiess AP, Sgouros G, Vaidyanathan G, Zalutsky MR, Pomper MG Journal of Nuclear Medicine 2022 Feb 63 259-267 -
Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T
Hartrampf PE, Weinzierl FX, Serfling SE, Pomper MG, Rowe SP, Higuchi T, Seitz AK, Kübler H, Buck AK, Werner RA Cancers 2022 Feb 14 -
First-in-human use of 11C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor
Coughlin JM, Du Y, Lesniak WG, Harrington CK, Brosnan MK, O’Toole R, Zandi A, Sweeney SE, Abdallah R, Wu Y, Holt DP, Hall AW, Dannals RF, Solnes L, Horti AG, Pomper MG EJNMMI Research 2022 12 -
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL
Werner RA, Habacha B, Lütje S, Bundschuh L, Higuchi T, Hartrampf P, Serfling SE, Derlin T, Lapa C, Buck AK, Essler M, Pienta KJ, Eisenberger MA, Markowski MC, Shinehouse L, Abdallah R, Salavati A, Lodge MA, Pomper MG, Gorin MA, Bundschuh RA, Rowe SP Molecular Imaging 2022 2022 -
Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET
Leung KH, Rowe SP, Leal JP, Ashrafinia S, Sadaghiani MS, Chung HW, Dalaie P, Tulbah R, Yin Y, VanDenBerg R, Werner RA, Pienta KJ, Gorin MA, Du Y, Pomper MG EJNMMI Research 2022 12 -
In Vivo Functional Assessment of Sodium-Glucose Cotransporters (SGLTs) Using [18F]Me4FDG PET in Rats
Matsusaka Y, Chen X, Arias-Loza P, Werner RA, Nose N, Sasaki T, Rowe SP, Pomper MG, Lapa C, Higuchi T Molecular Imaging 2022 2022 -
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using 68Ga-Pentixafor PET
Buck AK, Haug A, Dreher N, Lambertini A, Higuchi T, Lapa C, Weich A, Pomper MG, Wester HJ, Zehndner A, Schirbel A, Samnick S, Hacker M, Pichler V, Hahner S, Fassnacht M, Einsele H, Serfling SE, Werner RA Journal of Nuclear Medicine 2022 63 1687-1692 -
Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
Mena E, Rowe SP, Shih JH, Lindenberg L, Turkbey B, Fourquet A, Lin FI, Adler S, Eclarinal P, McKinney YL, Citrin DE, Dahut W, Wood BJ, Chang R, Levy E, Merino M, Gorin MA, Pomper MG, Pinto PA, Eary JF, Choyke PL, Pienta KJ Journal of Nuclear Medicine 2022 63 1184-1190 -
Piflufolastat F-18 (18F-DCFPyL) for PSMA PET imaging in prostate cancer
Voter AF, Werner RA, Pienta KJ, Gorin MA, Pomper MG, Solnes LB, Rowe SP Expert Review of Anticancer Therapy 2022 22 681-694 -
Molecular Imaging in Multiple Myeloma—Novel PET Radiotracers Improve Patient Management and Guide Therapy
von Hinten J, Kircher M, Dierks A, Pfob CH, Higuchi T, Pomper MG, Rowe SP, Buck AK, Samnick S, Werner RA, Lapa C Frontiers in Nuclear Medicine 2022 2 -
Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT
Mihatsch PW, Beissert M, Pomper MG, Bley TA, Seitz AK, Kübler H, Buck AK, Rowe SP, Serfling SE, Hartrampf PE, Werner RA Cancers 2022 Jan 14 -
Molecular Imaging-Derived Biomarker of Cardiac Nerve Integrity — Introducing High NET Affinity PET Probe 18F-AF78
Chen X, Werner RA, Koshino K, Nose N, Mühlig S, Rowe SP, Pomper MG, Lapa C, Decker M, Higuchi T Theranostics 2022 12 4446-4458 -
A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
Boinapally S, Ahn HH, Cheng B, Brummet M, Nam H, Gabrielson KL, Banerjee SR, Minn I, Pomper MG Scientific reports 2021 Dec 11 -
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
Park JS, Kam TI, Lee S, Park H, Oh Y, Kwon SH, Song JJ, Kim D, Kim H, Jhaldiyal A, Na DH, Lee KC, Park EJ, Pomper MG, Pletnikova O, Troncoso JC, Ko HS, Dawson VL, Dawson TM, Lee S Acta Neuropathologica Communications 2021 Dec 9 -
Targeted delivery of cytotoxic proteins to prostate cancer via conjugation to small molecule urea-based PSMA inhibitors
Rogers OC, Rosen DM, Antony L, Harper HM, Das D, Yang X, Minn I, Mease RC, Pomper MG, Denmeade SR Scientific reports 2021 Dec 11 -
Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers
Ahn HH, Carrington C, Hu Y, Liu Hw, Ng C, Nam H, Park A, Stace C, West W, Mao HQ, Pomper MG, Ullman CG, Minn I Scientific reports 2021 Dec 11 -
Forebrain Shh overexpression improves cognitive function and locomotor hyperactivity in an aneuploid mouse model of Down syndrome and its euploid littermates
Gao FJ, Klinedinst D, Fernandez FX, Cheng B, Savonenko A, Devenney B, Li Y, Wu D, Pomper MG, Reeves RH Acta Neuropathologica Communications 2021 Dec 9 -
A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging
Zhang J, Rakhimbekova A, Duan X, Yin Q, Foss CA, Fan Y, Xu Y, Li X, Cai X, Kutil Z, Wang P, Yang Z, Zhang N, Pomper MG, Wang Y, Bařinka C, Yang X Nature communications 2021 Dec 12 -
Whole-body [18 f]fdg pet/ct can alter diagnosis in patients with suspected rheumatic disease
Fröhlich M, Serfling S, Higuchi T, Pomper MG, Rowe SP, Schmalzing M, Tony HP, Gernert M, Strunz PP, Portegys J, Schwaneck EC, Gadeholt O, Weich A, Buck AK, Bley TA, Guggenberger KV, Werner RA Diagnostics 2021 Nov 11 -
Prospective, single-arm trial evaluating changes in uptake patterns on prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL PET/CT in patients with castration-resistant prostate cancer starting abiraterone or enzalutamide
Zukotynski KA, Emmenneger U, Hotte S, Kapoor A, Fu W, Blackford AL, Valliant J, Bénard F, Kim CK, Markowski MC, Eisenberger MA, Antonarakis ES, Pienta KJ, Gorin MA, Lubanovic M, Kim J, Pomper MG, Cho SY, Rowe SP Journal of Nuclear Medicine 2021 Oct 62 -
CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer
Yan Y, Narayan A, Cho S, Cheng Z, Liu JO, Zhu H, Wang G, Wharram B, Lisok A, Brummet M, Saeki H, Huang T, Gabrielson K, Gabrielson E, Cope L, Kanaan YM, Afsari A, Naab T, Yfantis HG, Ambs S, Pomper MG, Sukumar S, Merino VF Oncogene 2021 Sep 40 5752-5763 -
First-in-human neuroimaging of soluble epoxide hydrolase using [18F]FNDP PET
Coughlin JM, Slania S, Du Y, Shinehouse LK, Brosnan MK, Azad BB, Holt DP, Fan H, Lesniak WG, Minn I, Rowe SP, Dannals RF, Horti AG, Pomper MG European Journal of Nuclear Medicine and Molecular Imaging 2021 Sep 48 3122-3128 -
Preclinical Evaluation of 213Bi- and 225Ac-Labeled Low- Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate Cancer
Banerjee SR, Lisok A, Minn I, Josefsson A, Kumar V, Brummet M, Boinapally S, Brayton C, Mease RC, Sgouros G, Hobbs RF, Pomper MG Journal of Nuclear Medicine 2021 Jul 62 980-988 -
Scalable Purification of Plasmid DNA Nanoparticles by Tangential Flow Filtration for Systemic Delivery
Liu HW, Hu Y, Ren Y, Nam H, Santos JL, Ng S, Gong L, Brummet M, Carrington CA, Ullman CG, Pomper MG, Minn I, Mao HQ ACS Applied Materials and Interfaces 2021 Jul 13 30326-30336 -
A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia
Coughlin JM, Yang K, Marsman A, Pradhan S, Wang M, Ward RE, Bonekamp S, Ambinder EB, Higgs CP, Kim PK, Edwards JA, Varvaris M, Wang H, Posporelis S, Ma S, Tsujimura T, Edden RA, Pomper MG, Sedlak TW, Fournier M, Schretlen DJ, Cascella NG, Barker PB, Sawa A Molecular psychiatry 2021 Jul 26 3502-3511 -
A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177–labeled Prostate-specific Membrane Antigen–targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
Sadaghiani MS, Sheikhbahaei S, Werner RA, Pienta KJ, Pomper MG, Solnes LB, Gorin MA, Wang NY, Rowe SP European urology 2021 Jul 80 82-94 -
Cellular and Molecular Imaging with SPECT and PET in Brain Tumors
Sadaghiani MS, Sheikhbahaei S, Rowe SP, Pomper MG, Solnes LB Radiologic Clinics of North America 2021 May 59 363-375 -
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [111In]In-XYIMSR-01 for phase I regulatory approval
De Silva RA, Gorin MA, Mease RC, Minn I, Lisok A, Plyku D, Nimmagadda S, Allaf ME, Yang X, Sgouros G, Rowe SP, Pomper MG Journal of Labelled Compounds and Radiopharmaceuticals 2021 May 64 243-250 -
Dual contrast agents for fluorescence and photoacoustic imaging: Evaluation in a murine model of prostate cancer
Lesniak WG, Wu Y, Kang J, Boinapally S, Ray Banerjee S, Lisok A, Jablonska A, Boctor EM, Pomper MG Nanoscale 2021 May 13 9217-9228 -
Measurement of PET Quantitative Bias In Vivo
Lodge MA, Lesniak W, Gorin MA, Pienta KJ, Rowe SP, Pomper MG Journal of Nuclear Medicine 2021 May 62 732-737 -
Theranostics in oncology—thriving, now more than ever
Werner RA, Higuchi T, Pomper MG, Rowe SP Diagnostics 2021 Apr 11 -
Triptolide: Reflections on two decades of research and prospects for the future
Tong L, Zhao Q, Datan E, Lin GQ, Minn I, Pomper MG, Yu B, Romo D, He QL, Liu JO Natural Product Reports 2021 Apr 38 843-860 -
Effect of point-spread function reconstruction for indeterminate PSMA-RADS-3A lesions on PSMA-targeted PET imaging of men with prostate cancer
Khatri W, Chung HW, Werner RA, Leal JP, Pienta KJ, Lodge MA, Gorin MA, Pomper MG, Rowe SP Diagnostics 2021 Apr 11 -
High interobserver agreement for the standardized reporting system SSTR-RADS 1.0 on somatostatin receptor PET/CT
Werner RA, Derlin T, Rowe SP, Bundschuh L, Sheikh GT, Pomper MG, Schulz S, Higuchi T, Buck AK, Bengel FM, Bundschuh RA, Lapa C Journal of Nuclear Medicine 2021 Apr 62 514-520 -
Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules
Slania SL, Das D, Lisok A, Du Y, Jiang Z, Mease RC, Rowe SP, Nimmagadda S, Yang X, Pomper MG Journal of Medicinal Chemistry 2021 Apr 64 4059-4070 -
Imaging Enterobacterales infections in patients using pathogen-specific positron emission tomography
Ordonez AA, Wintaco LM, Mota F, Restrepo AF, Bedoya CA, Reyes CF, Uribe LG, Abhishek S, Alessio FR, Holt DP, Dannals RF, Rowe SP, Castillo VR, Pomper MG, Granados U, Jain SK Science translational medicine 2021 Apr 13 -
CXCR4-directed pet/ct in patients with newly diagnosed neuroendocrine carcinomas
Weich A, Werner RA, Buck AK, Hartrampf PE, Serfling SE, Scheurlen M, Wester HJ, Meining A, Kircher S, Higuchi T, Pomper MG, Rowe SP, Lapa C, Kircher M Diagnostics 2021 Apr 11 -
18F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography
Hu F, Morris PJ, Bonaventura J, Fan H, Mathews WB, Holt DP, Lam S, Boehm M, Dannals RF, Pomper MG, Michaelides M, Horti AG European Journal of Medicinal Chemistry 2021 Mar 213 -
Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer
Vaidyanathan G, Mease RC, Minn I, Choi J, Chen Y, Shallal H, Kang CM, McDougald D, Kumar V, Pomper MG, Zalutsky MR Nuclear Medicine and Biology 2021 Mar 94-95 67-80 -
Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient–Control Differences
Plavén-Sigray P, Matheson GJ, Coughlin JM, Hafizi S, Laurikainen H, Ottoy J, De Picker L, Rusjan P, Hietala J, Howes OD, Mizrahi R, Morrens M, Pomper MG, Cervenka S Biological Psychiatry 2021 Feb 89 e5-e8 -
Current and future perspectives on functional molecular imaging in nephro-urology: Theranostics on the horizon
Toyama Y, Werner RA, Ruiz-Bedoya CA, Ordonez AA, Takase K, Lapa C, Jain SK, Pomper MG, Rowe SP, Higuchi T Theranostics 2021 11 6105-6119 -
A Learned Reconstruction Network for SPECT Imaging
Shao W, Pomper MG, Du Y IEEE Transactions on Radiation and Plasma Medical Sciences 2021 Jan 5 26-34 -
The Number of Frames on ECG-Gated 18F-FDG Small Animal PET Has a Significant Impact on LV Systolic and Diastolic Functional Parameters
Eissler C, Werner RA, Arias-Loza P, Nose N, Chen X, Pomper MG, Rowe SP, Lapa C, Buck AK, Higuchi T Molecular Imaging 2021 2021 -
Prostate-specific membrane antigen (Psma)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to psma-expressing prostate tumors
Ngen EJ, Chen Y, Azad BB, Boinapally S, Jacob D, Lisok A, Shen C, Hossain MS, Jin J, Bhujwalla ZM, Pomper MG, Banerjee SR Nanotheranostics 2021 5 182-196 -
Prostate Cancer Theranostics
Rowe SP, Sadaghiani MS, Werner RA, Higuchi T, Derlin T, Solnes LB, Pomper MG 2021 Jan 1117-1130 -
Central Nervous System Molecular Imaging
Solnes LB, Jacobs AH, Coughlin JM, Du Y, Goel R, Hammoud DA, Pomper MG 2021 Jan 1261-1285 -
Subtherapeutic Photodynamic Treatment Facilitates Tumor Nanomedicine Delivery and Overcomes Desmoplasia
Overchuk M, Harmatys KM, Sindhwani S, Rajora MA, Koebel A, Charron DM, Syed AM, Chen J, Pomper MG, Wilson BC, Chan WC, Zheng G Nano Letters 2021 Jan 21 344-352 -
Detection of Early Progression with 18F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy
Markowski MC, Velho PI, Eisenberger MA, Pomper MG, Pienta KJ, Gorin MA, Antonarakis ES, Denmeade SR, Rowe SP Journal of Nuclear Medicine 2021 62 1270-1273 -
A three-stage, deep learning, ensemble approach for prognosis in patients with Parkinson’s disease
Leung KH, Rowe SP, Pomper MG, Du Y EJNMMI Research 2021 11 -
Iterative Fluence Compensation and Spectral Unmixing for Spectroscopic Photoacoustic Imaging
Wu Y, Kang J, Lesniak WG, Pomper MG, Boctor EM IEEE International Ultrasonics Symposium, IUS 2021 -
Correction to: Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection (Journal of Neuroinflammation, (2020), 17, 1, (273), 10.1186/s12974-020-01949-4)
Mahmud FJ, Du Y, Greif E, Boucher T, Dannals RF, Mathews WB, Pomper MG, Sysa-Shah P, Metcalf Pate KA, Lyons C, Carlson B, Chacona M, Brown AM Journal of Neuroinflammation 2020 Dec 17 -
A physics-guided modular deep-learning based automated framework for tumor segmentation in PET
Leung KH, Marashdeh W, Wray R, Ashrafinia S, Pomper MG, Rahmim A, Jha AK Physics in medicine and biology 2020 Dec 65 -
Recent updates and developments in PET imaging of prostate cancer
Rowe SP, Johnson GB, Pomper MG, Gorin MA, Behr SC Abdominal Radiology 2020 Dec 45 4063-4072 -
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting
Miyahira AK, Pienta KJ, Babich JW, Bander NH, Calais J, Choyke P, Hofman MS, Larson SM, Lin FI, Morris MJ, Pomper MG, Sandhu S, Scher HI, Tagawa ST, Williams S, Soule HR Prostate 2020 Nov 80 1273-1296 -
The prostate-specific membrane antigen (PSMA)-targeted radiotracer 18F-DCFPyL detects tumor neovasculature in metastatic, advanced, radioiodine-refractory, differentiated thyroid cancer
Santhanam P, Russell J, Rooper LM, Ladenson PW, Pomper MG, Rowe SP Medical Oncology 2020 Nov 37 -
Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection
Mahmud FJ, Du Y, Greif E, Boucher T, Dannals RF, Mathews WB, Pomper MG, Sysa-Shah P, Metcalf Pate KA, Lyons C, Carlson B, Chacona M, Brown AM Journal of Neuroinflammation 2020 Sep 17 -
Development of 5D3-DM1: A novel anti-prostate-specific membrane antigen antibody-drug conjugate for PSMA-positive prostate cancer therapy
Huang CT, Guo X, Bařinka C, Lupold SE, Pomper MG, Gabrielson K, Raman V, Artemov D, Hapuarachchige S Molecular Pharmaceutics 2020 Sep 17 3392-3402 -
Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on 18F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate Cancer
Markowski MC, Sedhom R, Fu W, Gray JC, Eisenberger MA, Pomper MG, Pienta KJ, Gorin MA, Rowe SP Journal of Urology 2020 Sep 204 496-502 -
Prospective evaluation of 18F-DCFPyL PET/CT in detection of high-risk localized prostate cancer: Comparison with mpMRI
Gaur S, Mena E, Harmon SA, Lindenberg ML, Adler S, Ton AT, Shih JH, Mehralivand S, Merino MJ, Wood BJ, Pinto PA, Mease RC, Pomper MG, Choyke PL, Turkbey B American Journal of Roentgenology 2020 Sep 215 652-659 -
Engineered fragments of the psma-specific 5d3 antibody and their functional characterization
Novakova Z, Belousova N, Foss CA, Havlinova B, Gresova M, Das G, Lisok A, Prada A, Barinkova M, Hubalek M, Pomper MG, Barinka C International journal of molecular sciences 2020 Sep 21 1-21 -
A Glucose-Triptolide Conjugate Selectively Targets Cancer Cells under Hypoxia
Datan E, Minn I, Xu P, He QL, Ahn HH, Yu B, Pomper MG, Liu JO iScience 2020 Sep 23 -
d-glucose weighted chemical exchange saturation transfer (glucoCEST)-based dynamic glucose enhanced (DGE) MRI at 3T: early experience in healthy volunteers and brain tumor patients
Xu X, Sehgal AA, Yadav NN, Laterra J, Blair L, Blakeley J, Seidemo A, Coughlin JM, Pomper MG, Knutsson L, van Zijl PC Magnetic resonance in medicine 2020 Jul 84 247-262 -
A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)
Hasan H, Deek MP, Phillips R, Hobbs RF, Malek R, Radwan N, Kiess AP, Dipasquale S, Huang J, Caldwell T, Leitzel J, Wendler D, Wang H, Thompson E, Powell J, Dudley S, Deville C, Greco SC, Song DY, Deweese TL, Gorin MA, Rowe SP, Denmeade S, Markowski M, Antonarakis ES, Carducci MA, Eisenberger MA, Pomper MG, Pienta KJ, Paller CJ, Tran PT BMC Cancer 2020 Jun 20 -
cis-4-[18F]fluoro-L-proline Molecular Imaging Experimental Liver Fibrosis
Cao Q, Lu X, Azad BB, Pomper M, Smith M, He J, Pi L, Ren B, Ying Z, Sichani BS, Morris M, Dilsizian V Frontiers in Molecular Biosciences 2020 May 7 -
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, Rowe SP, Ross AE, Gorin MA, Deville C, Greco SC, Wang H, Denmeade SR, Paller CJ, Dipasquale S, Deweese TL, Song DY, Wang H, Carducci MA, Pienta KJ, Pomper MG, Dicker AP, Eisenberger MA, Alizadeh AA, Diehn M, Tran PT JAMA Oncology 2020 May 6 650-659 -
Long-Circulating Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostic Agent
Overchuk M, Damen MP, Harmatys KM, Pomper MG, Chen J, Zheng G Photochemistry and Photobiology 2020 May 96 718-724 -
(S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging
Duan X, Liu F, Kwon H, Byun Y, Minn I, Cai X, Zhang J, Pomper MG, Yang Z, Xi Z, Yang X Journal of Medicinal Chemistry 2020 Apr 63 3563-3576 -
Prostate-specific membrane antigen (PSMA) imaging: The past is prologue and the future is scintillating
Rowe SP, Gorin MA, Pomper MG Translational Andrology and Urology 2020 Apr 9 840-842 -
Appropriate use criteria for imaging evaluation of biochemical recurrence of prostate cancer after definitive primary treatment
Jadvar H, Ballas LK, Choyke PL, Fanti S, Gulley JL, Herrmann K, Hope TA, Klitzke AK, Oldan JD, Pomper MG, Rowe SP, Subramaniam RM, Taneja SS, Vargas HA, Ahuja S Journal of Nuclear Medicine 2020 Apr 61 552-562 -
Characterizing the link between glial activation and changed functional connectivity in national football league players using multimodal neuroimaging
Peters ME, Rahman S, Coughlin JM, Pomper MG, Sair HI Journal of Neuropsychiatry and Clinical Neurosciences 2020 Apr 32 191-195 -
Novel β- And γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen
Kim K, Kwon H, Barinka C, Motlova L, Nam S, Choi D, Ha H, Nam H, Son SH, Minn I, Pomper MG, Yang X, Kutil Z, Byun Y Journal of Medicinal Chemistry 2020 Mar 63 3261-3273 -
Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear Medicine
Solnes LB, Werner RA, Jones KM, Sadaghiani MS, Bailey CR, Lapa C, Pomper MG, Rowe SP Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Mar 61 311-318 -
High Availability of the a7-Nicotinic Acetylcholine Receptor in Brains of Individuals with Mild Cognitive Impairment: A Pilot Study Using 18F-ASEM PET
Coughlin JM, Rubin LH, Du Y, Rowe SP, Crawford JL, Rosenthal HB, Frey SM, Marshall ES, Shinehouse LK, Chen A, Speck CL, Wang Y, Lesniak WG, Minn I, Bakker A, Kamath V, Smith GS, Albert MS, Azad BB, Dannals RF, Horti A, Wong DF, Pomper MG Journal of Nuclear Medicine 2020 Mar 61 423-426 -
Online Prostate-Specific Membrane Antigen and Positron Emission Tomography–Guided Radiation Therapy for Oligometastatic Prostate Cancer
Hrinivich WT, Phillips R, Da Silva AJ, Radwan N, Gorin MA, Rowe SP, Pienta KJ, Pomper MG, Wong J, Tran PT, Kang-Hsin Wang K Advances in Radiation Oncology 2020 Mar 5 260-268 -
Prospective comparison of PET imaging with PSMA-targeted 18F-DCFPyL versus NA18F for bone lesion detection in patients with metastatic prostate cancer
Rowe SP, Li X, Trock BJ, Werner RA, Frey S, DiGianvittorio M, Keith Bleiler J, Reyes DK, Abdallah R, Pienta KJ, Gorin MA, Pomper MG Journal of Nuclear Medicine 2020 Feb 61 183-188 -
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake
Werner RA, Bundschuh RA, Bundschuh L, Lapa C, Yin Y, Javadi MS, Buck AK, Higuchi T, Pienta KJ, Pomper MG, Lodge MA, Gorin MA, Rowe SP Molecular Imaging and Biology 2020 Feb 22 190-197 -
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake
Sahakyan K, Li X, Lodge MA, Werner RA, Bundschuh RA, Bundschuh L, Kulkarni HR, Schuchardt C, Baum RP, Pienta KJ, Pomper MG, Ross AE, Gorin MA, Rowe SP Molecular Imaging and Biology 2020 Feb 22 181-189 -
Letter to the Editor re: “Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake”
Werner RA, Pienta KJ, Pomper MG, Gorin MA, Rowe SP, Lodge MA, Bundschuh RA Molecular Imaging and Biology 2020 Feb 22 19-21 -
Optimization of osmotic blood-brain barrier opening to enable intravital microscopy studies on drug delivery in mouse cortex
Chu C, Jablonska A, Lesniak WG, Thomas AM, Lan X, Linville RM, Li S, Searson PC, Liu G, Pearl M, Pomper MG, Janowski M, Magnus T, Walczak P Journal of Controlled Release 2020 Jan 317 312-321 -
Discussions with leaders: A conversation between Martin pomper and Peter Choyke
Pomper MG, Choyke PL Journal of Nuclear Medicine 2020 Jan 61 3-5 -
Prospective evaluation of PSMA-targeted 18F-DCFPYL PET/CT in men with biochemical failure after radical prostatectomy for prostate cancer
Rowe SP, Campbell SP, Mana-Ay M, Szabo Z, Allaf ME, Pienta KJ, Pomper MG, Ross AE, Gorin MA Journal of Nuclear Medicine 2020 Jan 61 58-61 -
Preclinical evaluation of 203/212Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer
Banerjee SR, Minn I, Kumar V, Josefsson A, Lisok A, Brummet M, Chen J, Kiess AP, Baidoo K, Brayton C, Mease RC, Brechbiel M, Sgouros G, Hobbs RF, Pomper MG Journal of Nuclear Medicine 2020 Jan 61 80-88 -
18F-labeled, PSMA-targeted radiotracers: Leveraging the advantages of radiofluorination for prostate cancer molecular imaging
Werner RA, Derlin T, Lapa C, Sheikbahaei S, Higuchi T, Giesel FL, Behr S, Drzezga A, Kimura H, Buck AK, Bengel FM, Pomper MG, Gorin MA, Rowe SP Theranostics 2020 10 1-16 -
Comparison of CNN-based Approaches for Detection of COVID-19 on Chest X-ray Images
Leung KH, Rowe SP, Pomper MG, Du Y 2020 -
PET imaging of soluble epoxide hydrolase in non-human primate brain with [18F]FNDP
Du Y, Minn I, Foss C, Lesniak WG, Hu F, Dannals RF, Pomper MG, Horti AG EJNMMI Research 2020 10 -
Enhancement of radiotherapy with human mesenchymal stem cells containing gold nanoparticles
Pullambhatla M, Rowe SP, Lisok A, Wang Y, Todd GP, Danilkovitch A, Pomper MG Tomography 2020 6 373-378 -
Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer
Shen CJ, Minn I, Hobbs RF, Chen Y, Josefsson A, Brummet M, Banerjee SR, Brayton CF, Mease RC, Pomper MG, Kiess AP Theranostics 2020 10 2888-2896 -
Optimum imaging strategies for advanced prostate cancer: ASCO guideline
Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA Journal of Clinical Oncology 2020 38 1963-1996 -
In vitro and in vivo characterization of dibenzothiophene derivatives [125I]iodo-ASEM and [18F]ASEM as radiotracers of homo- And heteromeric α7 nicotinic acetylcholine receptors
Donat CK, Hansen HH, Hansen HD, Mease RC, Horti AG, Pomper MG, L’Estrade ET, Herth MM, Peters D, Knudsen GM, Mikkelsen JD Molecules 2020 25 -
Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [124I]FIAU PET/CT
Cho SY, Rowe SP, Jain SK, Schon LC, Yung RC, Nayfeh TA, Bingham CO, Foss CA, Nimmagadda S, Pomper MG Molecular Imaging 2020 19 -
Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer
Hapuarachchige S, Huang CT, Donnelly MC, Bařinka C, Lupold SE, Pomper MG, Artemov D Molecular Pharmaceutics 2020 Jan 17 98-108 -
Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma
Park JS, Oh Y, Park YJ, Park O, Yang H, Slania S, Hummers LK, Shah AA, An HT, Jang J, Horton MR, Shin J, Dietz HC, Song E, Na DH, Park EJ, Kim K, Lee KC, Roschke VV, Hanes J, Pomper MG, Lee S Nature communications 2019 Dec 10 -
Imager-4D: New Software for Viewing Dynamic PET Scans and Extracting Radiomic Parameters from PET Data
Rowe SP, Solnes LB, Yin Y, Kitchen G, Lodge MA, Karakatsanis NA, Rahmim A, Pomper MG, Leal JP Journal of Digital Imaging 2019 Dec 32 1071-1080 -
High-potency ligands for DREADD imaging and activation in rodents and monkeys
Bonaventura J, Eldridge MA, Hu F, Gomez JL, Sanchez-Soto M, Abramyan AM, Lam S, Boehm MA, Ruiz C, Farrell MR, Moreno A, Galal Faress IM, Andersen N, Lin JY, Moaddel R, Morris PJ, Shi L, Sibley DR, Mahler SV, Nabavi S, Pomper MG, Bonci A, Horti AG, Richmond BJ, Michaelides M Nature communications 2019 Dec 10 -
Imaging and Characterization of Macrophage Distribution in Mouse Models of Human Prostate Cancer
Copeland BT, Shallal H, Shen C, Pienta KJ, Foss CA, Pomper MG Molecular Imaging and Biology 2019 Dec 21 1054-1063 -
177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy
Banerjee SR, Kumar V, Lisok A, Chen J, Minn I, Brummet M, Boinapally S, Cole M, Ngen E, Wharram B, Brayton C, Hobbs RF, Pomper MG European Journal of Nuclear Medicine and Molecular Imaging 2019 Nov 46 2545-2557 -
Opportunities in precision psychiatry using PET neuroimaging in psychosis
Coughlin JM, Horti AG, Pomper MG Neurobiology of Disease 2019 Nov 131 -
From the Reading Room to the Courtroom—The Use of Molecular Radionuclide Imaging in Criminal Trials
Werner RA, Savoie B, Javadi MS, Pomper MG, Higuchi T, Lapa C, Rowe SP Journal of the American College of Radiology 2019 Nov 16 1612-1617 -
A side-by-side evaluation of [18F]FDOPA enantiomers for noninvasive detection of neuroendocrine tumors by positron emission tomography
Narayan A, Yan Y, Lisok A, Brummet M, Pomper MG, Lesniak WG, Dannals RF, Merino VF, Azad BB Oncotarget 2019 Oct 10 5731-5744 -
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer
Paller CJ, Piana D, Eshleman JR, Riel S, Denmeade SR, Isaacsson Velho P, Rowe SP, Pomper MG, Antonarakis ES, Luo J, Eisenberger MA Prostate 2019 Oct 79 1597-1603 -
The Correlation Between [68Ga]DOTATATE PET/CT and Cell Proliferation in Patients With GEP-NENs
Yu J, Li N, Li J, Lu M, Leal JP, Tan H, Su H, Fan Y, Zhang Y, Zhao W, Zhu H, Pomper MG, Zhou Y, Yang Z Molecular Imaging and Biology 2019 Oct 21 984-990 -
Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
Meyer AR, Carducci MA, Denmeade SR, Markowski MC, Pomper MG, Pierorazio PM, Allaf ME, Rowe SP, Gorin MA Annals of Nuclear Medicine 2019 Aug 33 617-623 -
Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy
Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y, Pomper MG, Abraham TP, Tsui B, Lodge MA, Schindler TH, Roselle Abraham M Journal of Nuclear Cardiology 2019 Aug 26 1243-1253 -
PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration
Lesniak WG, Chu C, Jablonska A, Behnam Azad B, Zwaenepoel O, Zawadzki M, Lisok A, Pomper MG, Walczak P, Gettemans J, Janowski M European Journal of Nuclear Medicine and Molecular Imaging 2019 Aug 46 1940-1951 -
Correction to: Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy (Journal of Nuclear Cardiology, (2019), 26, 4, (1243-1253), 10.1007/s12350-017-1155-x)
Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y, Pomper MG, Abraham TP, Tsui B, Lodge MA, Schindler TH, Abraham MR Journal of Nuclear Cardiology 2019 Aug 26 1254 -
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease
Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko HS Neuron 2019 Aug 103 627-641.e7 -
Enhancing CAR T-cell therapy through cellular imaging and radiotherapy
Minn I, Rowe SP, Pomper MG The Lancet Oncology 2019 Aug 20 e443-e451 -
Impact of Tumor Burden on Quantitative [68Ga] DOTATOC Biodistribution
Werner RA, Hänscheid H, Leal JP, Javadi MS, Higuchi T, Lodge MA, Buck AK, Pomper MG, Lapa C, Rowe SP Molecular Imaging and Biology 2019 Aug 21 790-798 -
The next era of renal radionuclide imaging: novel PET radiotracers
Werner RA, Chen X, Lapa C, Koshino K, Rowe SP, Pomper MG, Javadi MS, Higuchi T European Journal of Nuclear Medicine and Molecular Imaging 2019 Aug 46 1773-1786 -
Recent updates on molecular imaging reporting and data systems (MI-RADS) for theranostic radiotracers—navigating pitfalls of SSTR-and PSMA-targeted PET/CT
Werner RA, Thackeray JT, Pomper MG, Bengel FM, Gorin MA, Derlin T, Rowe SP Journal of Clinical Medicine 2019 Jul 8 -
Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls
Sheikhbahaei S, Werner RA, Solnes LB, Pienta KJ, Pomper MG, Gorin MA, Rowe SP Seminars in Nuclear Medicine 2019 Jul 49 255-270 -
Evaluation of PSMA-Targeted PAMAM Dendrimer Nanoparticles in a Murine Model of Prostate Cancer
Lesniak WG, Boinapally S, Banerjee SR, Behnam Azad B, Foss CA, Shen C, Lisok A, Wharram B, Nimmagadda S, Pomper MG Molecular Pharmaceutics 2019 Jun 16 2590-2604 -
Development of [18F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide
Lesniak WG, Mease RC, Chatterjee S, Kumar D, Lisok A, Wharram B, Kalagadda VR, Emens LA, Pomper MG, Nimmagadda S Molecular Imaging 2019 Jun 18 -
SPECT/CT Imaging of Mycobacterium tuberculosis Infection with [125I]anti-C3d mAb
Foss CA, Kulik L, Ordonez AA, Jain SK, Michael Holers V, Thurman JM, Pomper MG Molecular Imaging and Biology 2019 Jun 21 473-481 -
Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [18F]DCFPyL PET/CT
Yin Y, Campbell SP, Markowski MC, Pierorazio PM, Pomper MG, Allaf ME, Rowe SP, Gorin MA Molecular Imaging and Biology 2019 Jun 21 567-573 -
Novel structured reporting systems for theranostic radiotracers
Werner RA, Bundschuh RA, Bundschuh L, Fanti S, Javadi MS, Higuchi T, Weich A, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Herrmann K, Lapa C, Rowe SP Journal of Nuclear Medicine 2019 May 60 577-584 -
A distinct advantage to intraarterial delivery of 89Zr-bevacizumab in PET imaging of mice with and without osmotic opening of the blood–brain barrier
Lesniak WG, Chu C, Jablonska A, Du Y, Pomper MG, Walczak P, Janowski M Journal of Nuclear Medicine 2019 May 60 617-622 -
MRI Assessment of Prostate-Specific Membrane Antigen (PSMA) Targeting by a PSMA-Targeted Magnetic Nanoparticle: Potential for Image-Guided Therapy
Ngen EJ, Benham Azad B, Boinapally S, Lisok A, Brummet M, Jacob D, Pomper MG, Banerjee SR Molecular Pharmaceutics 2019 May 16 2060-2068 -
Novel Functional Renal PET Imaging with 18F-FDS in Human Subjects
Werner RA, Ordonez AA, Sanchez-Bautista J, Marcus C, Lapa C, Rowe SP, Pomper MG, Leal JP, Lodge MA, Javadi MS, Jain SK, Higuchi T Clinical nuclear medicine 2019 May 44 410-411 -
Hereditary Spherocytosis Presenting as Diffuse Bone Marrow Activation and Splenomegaly on PSMA-Targeted 18F-DCFPyL PET/CT
Gomez E, Tran PT, Pienta KJ, Pomper MG, Gorin MA, Rowe SP Clinical nuclear medicine 2019 Apr 44 e313-e314 -
Kinetic Control in Assembly of Plasmid DNA/Polycation Complex Nanoparticles
Hu Y, He Z, Hao Y, Gong L, Pang M, Howard GP, Ahn HH, Brummet M, Chen K, Liu HW, Ke X, Zhu J, Anderson CF, Cui H, Ullman CG, Carrington CA, Pomper MG, Seo JH, Mittal R, Minn I, Mao HQ ACS Nano 2019 Apr 13 10161-10178 -
Follow-up of lesions with equivocal radiotracer uptake on PSMA-targeted PET in patients with prostate cancer: Predictive values of the PSMA-RADS-3A and PSMA-RADS-3B categories
Yin Y, Werner RA, Higuchi T, Lapa C, Pienta KJ, Pomper MG, Gorin MA, Rowe SP Journal of Nuclear Medicine 2019 Apr 60 511-516 -
PSMA-targeted [ 18 F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework
Reyes DK, Demehri S, Werner RA, Pomper MG, Gorin MA, Rowe SP, Pienta KJ Urology Case Reports 2019 Mar 23 72-74 -
Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy
Zhao M, Liu M, Leal JP, Tsui BM, Wong DF, Pomper MG, Zhou Y PloS one 2019 Mar 14 -
Peptide-based PET quantifies target engagement of PD-L1 therapeutics
Kumar D, Lisok A, Dahmane E, McCoy M, Shelake S, Chatterjee S, Allaj V, Sysa-Shah P, Wharram B, Lesniak WG, Tully E, Gabrielson E, Jaffee EM, Poirier JT, Rudin CM, Gobburu JV, Pomper MG, Nimmagadda S Journal of Clinical Investigation 2019 Feb 129 616-630 -
Use of 18 F-ASEM PET to determine the availability of the a7-nicotinic acetylcholine receptor in recent-onset psychosis
Coughlin JM, Du Y, Crawford JL, Rubin LH, Azad BB, Lesniak WG, Horti AG, Schretlen DJ, Sawa A, Pomper MG Journal of Nuclear Medicine 2019 Feb 60 241-243 -
Long-circulating prostate-specific membrane antigen-targeted NIR phototheranostic agent
Overchuk M, Harmatys KM, Damen MP, Chen J, Pomper MG, Zheng G 2019 -
Compositional control of pDNA/lPEI nanoparticles using flash nanocomplexation to improve in vivo transfection efficiency and biocompatibility
Hu Y, Liu HW, Minn I, Pomper M, Mao HQ 2019 383 -
Preclinical Experimentation in Oncology
Nimmagadda S, Shelake S, Pomper MG 2019 Jan 569-582 -
PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)
Horti AG, Naik R, Foss CA, Minn I, Misheneva V, Du Y, Wang Y, Mathews WB, Wu Y, Hall A, LaCourse C, Ahn HH, Nam H, Lesniak WG, Valentine H, Pletnikova O, Troncoso JC, Smith MD, Calabresi PA, Savonenko AV, Dannals RF, Pletnikov MV, Pomper MG Proceedings of the National Academy of Sciences of the United States of America 2019 Jan 116 1686-1691 -
Imaging of prostate-specific membrane antigen with small-molecule PET radiotracers: From the bench to advanced clinical applications
Rowe SP, Gorin MA, Pomper MG Annual review of medicine 2019 Jan 70 461-477 -
Identifying recurrent malignant glioma after treatment using amide proton transfer-weighted MR imaging: A validation study with image-guided stereotactic biopsy
Jiang S, Eberhart CG, Lim M, Heo HY, Zhang Y, Blair L, Wen Z, Holdhoff M, Lin D, Huang P, Qin H, Quinones-Hinojosa A, Weingart JD, Barker PB, Pomper MG, Laterra J, Van Zijl PC, Blakeley JO, Zhou J Clinical Cancer Research 2019 Jan 25 552-561 -
The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study
Author Collaboration Ft, Paranjpe MD, Chen X, Liu M, Paranjpe I, Leal JP, Wang R, Pomper MG, Wong DF, Benzinger TL, Zhou Y NeuroImage: Clinical 2019 22 -
[68Ga]-pentixafor PET/CT for CXCR4-mediated imaging of vestibular schwannomas
Breun M, Monoranu CM, Kessler AF, Matthies C, Löhr M, Hagemann C, Schirbel A, Rowe SP, Pomper MG, Buck AK, Wester HJ, Ernestus RI, Lapa C Frontiers in Oncology 2019 9 -
Evaluation of 111 In-DOTA-5D3, a surrogate SPECT imaging agent for radioimmunotherapy of prostate-specific membrane antigen
Banerjee SR, Kumar V, Lisok A, Plyku D, Nováková Z, Brummet M, Wharram B, Barinka C, Hobbs R, Pomper MG Journal of Nuclear Medicine 2019 60 400-406 -
Can the interplay between androgen signaling and PSMA expression be leveraged for theranostic applications?
Batra JS, Pienta KJ, Pomper MG, Gorin MA, Rowe SP Translational Andrology and Urology 2019 8 S263-S264 -
CXCR4-directed imaging in solid tumors
Werner RA, Kircher S, Higuchi T, Kircher M, Schirbel A, Wester HJ, Buck AK, Pomper MG, Rowe SP, Lapa C Frontiers in Oncology 2019 9 -
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
Minn I, Huss DJ, Ahn HH, Chinn TM, Park A, Jones J, Brummet M, Rowe SP, Sysa-Shah P, Du Y, Levitsky HI, Pomper MG Science Advances 2019 5 -
Flash nanocomplexation as a scalable production method for therapeutic pdna/lpei nanoparticles
Liu HW, Hu Y, Minn I, Pomper M, Mao HQ 2019 301 -
Imaging glial activation in patients with post-treatment Lyme disease symptoms: A pilot study using [ 11 C]DPA-713 PET
Coughlin JM, Yang T, Rebman AW, Bechtold KT, Du Y, Mathews WB, Lesniak WG, Mihm EA, Frey SM, Marshall ES, Rosenthal HB, Reekie TA, Kassiou M, Dannals RF, Soloski MJ, Aucott JN, Pomper MG Journal of Neuroinflammation 2018 Dec 15 -
Interobserver agreement for the standardized reporting system PSMA-RADS 1.0 on18F-DCFPYL PET/CT imaging
Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Leal JP, Higuchi T, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Lapa C, Rowe SP Journal of Nuclear Medicine 2018 Dec 59 1857-1864 -
A comparison of prostate cancer bone metastases on 18 F-sodium fluoride and prostate specific membrane antigen ( 18 F-PSMA) PET/CT: Discordant uptake in the same lesion
Harmon SA, Mena E, Shih JH, Adler S, McKinney Y, Bergvall E, Mehralivand S, Sowalsky AG, Couvillon A, Madan RA, Gulley JL, Eary J, Mease RC, Pomper MG, Dahut WL, Turkbey B, Lindenberg L, Choyke PL Oncotarget 2018 Dec 9 37676-37688 -
Nanoparticle architecture preserves magnetic properties during coating to enable robust multi-modal functionality
Woodard LE, Dennis CL, Borchers JA, Attaluri A, Velarde E, Dawidczyk C, Searson PC, Pomper MG, Ivkov R Scientific reports 2018 Dec 8 -
Generative Adversarial Networks for the Creation of Realistic Artificial Brain Magnetic Resonance Images
Kazuhiro K, Werner RA, Toriumi F, Javadi MS, Pomper MG, Solnes LB, Verde F, Higuchi T, Rowe SP Tomography (Ann Arbor, Mich.) 2018 Dec 4 159-163 -
Tuning Pharmacokinetics to Improve Tumor Accumulation of a Prostate-Specific Membrane Antigen-Targeted Phototheranostic Agent
Harmatys KM, Overchuk M, Chen J, Ding L, Chen Y, Pomper MG, Zheng G Bioconjugate Chemistry 2018 Nov 29 3746-3756 -
A hyaluronic acid binding peptide-polymer system for treating osteoarthritis
Faust HJ, Sommerfeld SD, Rathod S, Rittenbach A, Ray Banerjee S, Tsui BM, Pomper M, Amzel ML, Singh A, Elisseeff JH Biomaterials 2018 Nov 183 93-101 -
Using deep-learning to predict outcome of patients with Parkinson's disease
Leung KH, Salmanpour MR, Saberi A, Klyuzhin IS, Sossi V, Jha AK, Pomper MG, Du Y, Rahmim A 2018 Nov -
Uptake of Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL in Cerebral Radionecrosis: Implications for Diagnostic Imaging of High-Grade Gliomas
Salas Fragomeni RA, Pienta KJ, Pomper MG, Gorin MA, Rowe SP Clinical nuclear medicine 2018 Nov 43 e419-e421 -
Biodistribution and radiation dosimetry of 124I-DPA-713, a PET radiotracer for macrophage-associated inflammation
Foss CA, Plyku D, Ordonez AA, Sanchez-Bautista J, Rosentha HB, Minn I, Lodge MA, Pomper MG, Sgouros G, Jain SK Journal of Nuclear Medicine 2018 Nov 59 1751-1756 -
Reproducibility of Cold Uptake Radiomics in 99m Tc-Sestamibi SPECT Imaging of Renal Cell Carcinoma
Ashrafinia S, Jones K, Agorin M, Prowe S, Javadi MS, Pomper MG, Allaf ME, Rahmim A 2018 Nov -
A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-Targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer
Harmon SA, Bergvall E, Mena E, Shih JH, Adler S, McKinney Y, Mehralivand S, Citrin DE, Couvillon A, Madan RA, Gulley JL, Mease RC, Jacobs PM, Pomper MG, Turkbey B, Choyke PL, Lindenberg ML Journal of Nuclear Medicine 2018 Nov 59 1665-1671 -
18F-XTRA PET for enhanced imaging of the extrathalamic α4β2 nicotinic acetylcholine receptor
Coughlin JM, Slania S, Du Y, Rosenthal HB, Lesniak WG, Minn I, Smith GS, Dannals RF, Kuwabara H, Wong DF, Wang Y, Horti AG, Pomper MG Journal of Nuclear Medicine 2018 Oct 59 1603-1608 -
Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications
Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Higuchi T, Weich A, Sheikhbahaei S, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Lapa C, Rowe SP Annals of Nuclear Medicine 2018 Oct 32 512-522 -
Peptide-Based 68 Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer
De Silva RA, Kumar D, Lisok A, Chatterjee S, Wharram B, Venkateswara Rao K, Mease R, Dannals RF, Pomper MG, Nimmagadda S Molecular Pharmaceutics 2018 Sep 15 3946-3952 -
Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data
Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, Mizrahi R, Pomper MG, Rusjan P, Veronese M, Wang Y, Cervenka S Biological Psychiatry 2018 Sep 84 433-442 -
Prostate-specific membrane antigen-targeted photoacoustic imaging of prostate cancer in vivo
Zhang HK, Chen Y, Kang J, Lisok A, Minn I, Pomper MG, Boctor EM Journal of Biophotonics 2018 Sep 11 -
Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group
Miyahira AK, Pienta KJ, Morris MJ, Bander NH, Baum RP, Fendler WP, Goeckeler W, Gorin MA, Hennekes H, Pomper MG, Sartor O, Tagawa ST, Williams S, Soule HR Prostate 2018 Aug 78 775-789 -
A Voice From the Past: Rediscovering the Virchow Node With Prostate-specific Membrane Antigen-targeted 18F-DCFPyL Positron Emission Tomography Imaging
Werner RA, Andree C, Javadi MS, Lapa C, Buck AK, Higuchi T, Pomper MG, Gorin MA, Rowe SP, Pienta KJ Urology 2018 Jul 117 18-21 -
Translocator protein (TSPO) and stress cascades in mouse models of psychosis with inflammatory disturbances
Fukudome D, Hayes LN, Faust TE, Foss CA, Kondo MA, Lee BJ, Saito A, Kano Si, Coughlin JM, Kamiya A, Pomper MG, Sawa A, Niwa M Schizophrenia Research 2018 Jul 197 492-497 -
Radioligand Therapy of Prostate Cancer with a Long-Lasting Prostate-Specific Membrane Antigen Targeting Agent 90Y-DOTA-EB-MCG
Wang Z, Jacobson O, Tian R, Mease RC, Kiesewetter DO, Niu G, Pomper MG, Chen X Bioconjugate Chemistry 2018 Jul 29 2309-2315 -
Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors
Vaidyanathan G, Kang CM, McDougald D, Minn I, Brummet M, Pomper MG, Zalutsky MR Nuclear Medicine and Biology 2018 Jul 62-63 18-30 -
SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: A proposed standardization framework
Werner RA, Solnes LB, Javadi MS, Weich A, Gorin MA, Pienta KJ, Higuchi T, Buck AK, Pomper MG, Rowe SP, Lapa C Journal of Nuclear Medicine 2018 Jul 59 1085-1091 -
Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent
Plyku D, Mena E, Rowe SP, Lodge MA, Szabo Z, Cho SY, Pomper MG, Sgouros G, Hobbs RF European Journal of Nuclear Medicine and Molecular Imaging 2018 Jun 45 989-998 -
Imaging of nonprostate cancers using PSMA-targeted radiotracers: Rationale, current state of the field, and a call to arms
Roberto AS, Amir T, Sheikhbahaei S, Harvey SC, Javadi MS, Solnes LB, Kiess AP, Allaf ME, Pomper MG, Gorin MA, Rowe SP Journal of Nuclear Medicine 2018 Jun 59 871-877 -
Desmin Phosphorylation Triggers Preamyloid Oligomers Formation and Myocyte Dysfunction in Acquired Heart Failure
Rainer PP, Dong P, Sorge M, Fert-Bober J, Holewinski RJ, Wang Y, Foss CA, An SS, Baracca A, Solaini G, Glabe CG, Pomper MG, Van Eyk JE, Tomaselli GF, Paolocci N, Agnetti G Circulation research 2018 May 122 e75-e83 -
Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer
Banerjee SR, Song X, Yang X, Minn I, Lisok A, Chen Y, Bui A, Chatterjee S, Chen J, van Zijl PC, McMahon MT, Pomper MG Chemistry - A European Journal 2018 May 24 7235-7242 -
Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy
Lu DY, Yalçin H, Yalçin F, Zhao M, Sivalokanathan S, Valenta I, Tahari A, Pomper MG, Abraham TP, Schindler TH, Abraham MR American Journal of Cardiology 2018 May 121 1081-1089 -
Molecularly targeted MR imaging agent in liver fibrosis: High sensitivity and low gadolinium mean high translational potential
Pomper MG, Lee S RADIOLOGY 2018 May 287 590-591 -
Molecular imaging of prostate cancer: Choosing the right agent
Rowe SP, Pomper MG, Gorin MA Journal of Nuclear Medicine 2018 May 59 787-788 -
PSMA-RADS Version 1.0: A Step Towards Standardizing the Interpretation and Reporting of PSMA–targeted PET Imaging Studies
Rowe SP, Pienta KJ, Pomper MG, Gorin MA European urology 2018 Apr 73 485-487 -
Low-level endogenous PSMA expression in nonprostatic tumor xenografts is sufficient for in vivo tumor targeting and imaging
Nimmagadda S, Pullambhatla M, Chen Y, Parsana P, Lisok A, Chatterjee S, Mease R, Rowe SP, Lupold S, Pienta KJ, Pomper MG Journal of Nuclear Medicine 2018 Mar 59 486-493 -
Molecular Imaging of CXCL12 Promoter-driven HSV1-TK Reporter Gene Expression
Alon L, Kraitchman DL, Schär M, Cortez A, Yadav NN, Krimins R, Johnston PV, McMahon MT, van Zijl PC, Nimmagadda S, Pomper MG, Bulte JW, Gilad AA Biotechnology and Bioprocess Engineering 2018 Mar 23 208-217 -
The Low-Affinity Binding of Second Generation Radiotracers Targeting TSPO is Associated with a Unique Allosteric Binding Site
Rojas C, Stathis M, Coughlin JM, Pomper M, Slusher BS Journal of Neuroimmune Pharmacology 2018 Mar 13 1-5 -
Flare on serial prostate-specific membrane antigen-targeted 18F-DCFPyL PET/CT examinations in castration-resistant prostate cancer: First observations
Zukotynski KA, Valliant J, Bénard F, Rowe SP, Kim CK, Pomper MG, Cho SY Clinical nuclear medicine 2018 Mar 43 213-216 -
Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation
Shenderov E, Gorin MA, Kim S, Johnson PT, Allaf ME, Partin AW, Pomper MG, Antonarakis ES, Pienta KJ, Rowe SP Urology Case Reports 2018 Mar 17 22-25 -
Proposal for a structured reporting system for prostate-specific membrane antigen-targeted PET imaging: PSMA-RADS version 1.0
Rowe SP, Pienta KJ, Pomper MG, Gorin MA Journal of Nuclear Medicine 2018 Mar 59 479-485 -
Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia
Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M, Vernon AC, Benke D, Pomper MG, Sawa A, Meyer U Molecular psychiatry 2018 Feb 23 323-334 -
Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach
Valenta I, Varga ZV, Valentine H, Cinar R, Horti A, Mathews WB, Dannals RF, Steele K, Kunos G, Wahl RL, Pomper MG, Wong DF, Pacher P, Schindler TH JACC: Cardiovascular Imaging 2018 Feb 11 320-332 -
[125 I]IodoDPA-713 binding to 18 kDa translocator protein (TSPO) in a mouse model of intracerebral hemorrhage: Implications for neuroimaging
Bonsack F, Foss CA, Arbab AS, Alleyne CH, Pomper MG, Sukumari-Ramesh S Frontiers in Neuroscience 2018 Feb 12 -
Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Kaittanis C, Andreou C, Hieronymus H, Mao N, Foss CA, Eiber M, Weirich G, Panchal P, Gopalan A, Zurita J, Achilefu S, Chiosis G, Ponomarev V, Schwaiger M, Carver BS, Pomper MG, Grimm J Journal of Experimental Medicine 2018 Jan 215 159-175 -
Complete biochemical response after stereotactic ablative radiotherapy of an isolated prostate cancer pelvic soft tissue recurrence detected by 18F-DCFPyL PET/CT
Phillips RM, Gorin MA, Rowe SP, Pomper MG, Pienta KJ, Ross AE, Tran PT Urology Case Reports 2018 Jan 16 86-88 -
Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study
Gorin MA, Rowe SP, Patel HD, Vidal I, Mana-ay M, Javadi MS, Solnes LB, Ross AE, Schaeffer EM, Bivalacqua TJ, Partin AW, Pienta KJ, Szabo Z, De Marzo AM, Pomper MG, Allaf ME Journal of Urology 2018 Jan 199 126-132 -
Clinical impact of PSMA-based 18F–DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy
Mena E, Lindenberg ML, Shih JH, Adler S, Harmon S, Bergvall E, Citrin D, Dahut W, Ton AT, McKinney Y, Weaver J, Eclarinal P, Forest A, Afari G, Bhattacharyya S, Mease RC, Merino MJ, Pinto P, Wood BJ, Jacobs P, Pomper MG, Choyke PL, Turkbey B European Journal of Nuclear Medicine and Molecular Imaging 2018 Jan 45 4-11 -
Changes in [ 18 F]Fluorodeoxyglucose Activities in a Shockwave-Induced Traumatic Brain Injury Model Using Lithotripsy
Divani AA, Phan JA, Salazar P, Santacruz KS, Bachour O, Mahmoudi J, Zhu XH, Pomper MG Journal of neurotrauma 2018 Jan 35 187-194 -
Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma
Campbell SP, Baras AS, Ball MW, Kates M, Hahn NM, Bivalacqua TJ, Johnson MH, Pomper MG, Allaf ME, Rowe SP, Gorin MA Annals of Nuclear Medicine 2018 Jan 32 69-74 -
Correction: Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors [The Journal of Experimental Medicine, 1, (2018) 159-175] doi 10.1084/jem.20171052
Kaittanis C, Andreou C, Hieronymus H, Mao N, Foss CA, Eiber M, Weirich G, Panchal P, Gopalan A, Zurita J, Achilefu S, Chiosis G, Ponomarev V, Schwaiger M, Carver BS, Pomper MG, Grimm J Journal of Experimental Medicine 2018 Jan 215 377 -
The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [18F]ASEM
Coughlin JM, Du Y, Rosenthal HB, Slania S, Min Koo S, Park A, Solomon G, Vranesic M, Antonsdottir I, Speck CL, Rootes-Murdy K, Lerner A, Rowe SP, Wang Y, Lesniak WG, Minn I, Bakker A, Smith GS, Dannals RF, Kuwabara H, Horti A, Wong DF, Pomper MG NeuroImage 2018 Jan 165 118-124 -
Phenols as Diamagnetic T2-Exchange Magnetic Resonance Imaging Contrast Agents
Zhang J, Li Y, Slania S, Yadav NN, Liu J, Wang R, Zhang J, Pomper MG, van Zijl PC, Yang X, Liu G Chemistry - A European Journal 2018 Jan 24 1259-1263 -
The theranostic promise for Neuroendocrine Tumors in the late 2010s – Where do we stand, where do we go?
Werner RA, Weich A, Kircher M, Solnes LB, Javadi MS, Higuchi T, Buck AK, Pomper MG, Rowe SP, Lapa C Theranostics 2018 8 6088-6100 -
Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy
Rubin LH, Sacktor N, Creighton J, Du Y, Endres CJ, Pomper MG, Coughlin JM AIDS 2018 32 1661-1667 -
The theranostic promise for Neuroendocrine Tumors in the late 2010s – Where do we stand, where do we go?
Werner RA, Weich A, Kircher M, Solnes LB, Javadi MS, Higuchi T, Buck AK, Pomper MG, Rowe SP, Lapa C Theranostics 2018 8 6088-6100 -
PEGylated TRAIL ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cells
Park JS, Oh Y, Park O, Foss CA, Lim SM, Jo DG, Na DH, Pomper MG, Lee KC, Lee S Journal of Controlled Release 2017 Dec 267 163-171 -
A dextran-based probe for the targeted magnetic resonance imaging of tumours expressing prostate-specific membrane antigen
Liu G, Banerjee SR, Yang X, Yadav N, Lisok A, Jablonska A, Xu J, Li Y, Pomper MG, Van Zijl P Nature Biomedical Engineering 2017 Dec 1 977-982 -
Nano-sized metabolic precursors for heterogeneous tumor-targeting strategy using bioorthogonal click chemistry in vivo
Lee S, Jung S, Koo H, Na JH, Yoon HY, Shim MK, Park J, Kim JH, Lee S, Pomper MG, Kwon IC, Ahn CH, Kim K Biomaterials 2017 Dec 148 1-15 -
Future cancer research priorities in the USA: a Lancet Oncology Commission
Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A The Lancet Oncology 2017 Nov 18 e653-e706 -
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
Sheikhbahaei S, Afshar-Oromieh A, Eiber M, Solnes LB, Javadi MS, Ross AE, Pienta KJ, Allaf ME, Haberkorn U, Pomper MG, Gorin MA, Rowe SP European Journal of Nuclear Medicine and Molecular Imaging 2017 Nov 44 2117-2136 -
Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia
Werner RA, Sheikhbahaei S, Jones KM, Javadi MS, Solnes LB, Ross AE, Allaf ME, Pienta KJ, Lapa C, Buck AK, Higuchi T, Pomper MG, Gorin MA, Rowe SP Annals of Nuclear Medicine 2017 Nov 31 696-702 -
Polymeric nanoparticles as cancer-specific DNA delivery vectors to human hepatocellular carcinoma
Zamboni CG, Kozielski KL, Vaughan HJ, Nakata MM, Kim J, Higgins LJ, Pomper MG, Green JJ Journal of Controlled Release 2017 Oct 263 18-28 -
Imaging macrophage accumulation in a murine model of chronic pancreatitis with 125I-Iodo-DPA-713 SPECT/CT
Foss CA, Liu L, Mease RC, Wang H, Pasricha P, Pomper MG Journal of Nuclear Medicine 2017 Oct 58 1685-1690 -
18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation with Multiparametric MRI and Histopathology
Turkbey B, Mena E, Lindenberg L, Adler S, Bednarova S, Berman R, Ton AT, McKinney Y, Eclarinal P, Hill C, Afari G, Bhattacharyya S, Mease RC, Merino MJ, Jacobs PM, Wood BJ, Pinto PA, Pomper MG, Choyke PL Clinical nuclear medicine 2017 Oct 42 735-740 -
Cardiosphere-Derived Cells Demonstrate Metabolic Flexibility That Is Influenced by Adhesion Status
Afzal J, Chan A, Karakas MF, Woldemichael K, Vakrou S, Guan Y, Rathmell J, Wahl R, Pomper M, Foster DB, Aon MA, Tsui B, O'Rourke B, Abraham MR JACC: Basic to Translational Science 2017 Oct 2 543-560 -
Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas
Salas Fragomeni RA, Menke JR, Holdhoff M, Ferrigno C, Laterra JJ, Solnes LB, Javadi MS, Szabo Z, Pomper MG, Rowe SP Clinical nuclear medicine 2017 Oct 42 e433-e435 -
PSMA ligands for PET imaging of prostate cancer
Schwarzenboeck SM, Rauscher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, Asfhar-Oromieh A, Herrmann K, Eiber M Journal of Nuclear Medicine 2017 Oct 58 1545-1552 -
Multiparametric An Unusual Case MRI of and Penile PSMA-Targeted Prostate Cancer 18F-DCFPyL Uncovered PET/CT by
Rowe SP, Gorin MA, Chu LC, Pienta KJ, Pomper MG, Ross AE, Macura KJ Clinical nuclear medicine 2017 Oct 42 -
Corrigendum to “Rapid PD-L1 detection in tumors with PET using a highly specific peptide” [Biochemical and Biophysical Research Communications 483/1 (2017) 258–263] (S0006291X16322161) (10.1016/j.bbrc.2016.12.156)
Chatterjee S, Lesniak WG, Miller MS, Lisok A, Sikorska E, Wharram B, Kumar D, Gabrielson M, Pomper MG, Gabelli SB, Nimmagadda S Biochemical and Biophysical Research Communications 2017 Sep 491 1125 -
In vivo stem cell tracking with imageable nanoparticles that bind bioorthogonal chemical receptors on the stem cell surface
Lee S, Yoon HI, Na JH, Jeon S, Lim S, Koo H, Han SS, Kang SW, Park SJ, Moon SH, Park JH, Cho YW, Kim BS, Kim SK, Lee T, Kim D, Lee S, Pomper MG, Kwon IC, Kim K Biomaterials 2017 Sep 139 12-29 -
Prostate Cancer Local Recurrence Detected With Both 18F-Fluciclovine and PSMA-targeted 18F-DCFPyL PET/CT
Gorin MA, Pienta KJ, Pomper MG, Rowe SP Urology 2017 Sep 107 e9-e10 -
Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas
Jiang S, Eberhart CG, Zhang Y, Heo HY, Wen Z, Blair L, Qin H, Lim M, Quinones-Hinojosa A, Weingart JD, Barker PB, Pomper MG, Laterra J, van Zijl PC, Blakeley JO, Zhou J European Journal of Cancer 2017 Sep 83 9-18 -
Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA, Ellis RJ, Richie CT, Harvey BK, Dannals RF, Pomper MG, Bonci A, Michaelides M Science 2017 Aug 357 503-507 -
Defining the clinical utility of PSMA-targeted PET imaging of prostate cancer
Gorin MA, Pomper MG, Pienta KJ, Rowe SP BJU international 2017 Aug 120 160-161 -
Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits
Lind GE, Mou TC, Tamborini L, Pomper MG, De Micheli C, Conti P, Pinto A, Hansen KB Proceedings of the National Academy of Sciences of the United States of America 2017 Aug 114 E6942-E6951 -
Imaging of Prostate-Specific Membrane Antigen Using [18F]DCFPyL
Rowe SP, Gorin MA, Pomper MG PET Clinics 2017 Jul 12 289-296 -
Semiquantitative parameters in PSMA-Targeted PET imaging with 18F-DCFPyL: Variability in normal-organ uptake
Li X, Rowe SP, Leal JP, Gorin MA, Allaf ME, Ross AE, Pienta KJ, Lodge MA, Pomper MG Journal of Nuclear Medicine 2017 Jun 58 942-946 -
High Serum Stability of Collagen Hybridizing Peptides and Their Fluorophore Conjugates
Bennink LL, Smith DJ, Foss CA, Pomper MG, Li Y, Yu SM Molecular Pharmaceutics 2017 Jun 14 1906-1915 -
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
Radwan N, Phillips R, Ross A, Rowe SP, Gorin MA, Antonarakis ES, Deville C, Greco S, Denmeade S, Paller C, Song DY, Diehn M, Wang H, Carducci M, Pienta KJ, Pomper MG, DeWeese TL, Dicker A, Eisenberger M, Tran PT BMC Cancer 2017 Jun 17 -
Novel Monoclonal Antibodies Recognizing Human Prostate-Specific Membrane Antigen (PSMA) as Research and Theranostic Tools
Nováková Z, Foss CA, Copeland BT, Morath V, Baranová P, Havlínová B, Skerra A, Pomper MG, Barinka C Prostate 2017 May 77 749-764 -
Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry
Zlitni A, Yin M, Janzen N, Chatterjee S, Lisok A, Gabrielson KL, Nimmagadda S, Pomper MG, Foster FS, Valliant JF PloS one 2017 May 12 -
PET-measured longitudinal flow gradient correlates with invasive fractional flow reserve in CAD patients
Valenta I, Antoniou A, Marashdeh W, Leucker T, Kasper E, Jones SR, Dannals RF, Solnes L, Pomper MG, Schindler TH European heart journal cardiovascular Imaging 2017 May 18 538-548 -
Clinical Experience with 18F-Labeled Small Molecule Inhibitors of Prostate-Specific Membrane Antigen
Rowe SP, Gorin MA, Salas Fragomeni RA, Drzezga A, Pomper MG PET Clinics 2017 Apr 12 235-241 -
Imaging α4β2 Nicotinic Acetylcholine Receptors (nAChRs) in Baboons with [18F]XTRA, a Radioligand with Improved Specific Binding in Extra-Thalamic Regions
Kuwabara H, Gao Y, Stabin M, Coughlin J, Nimmagadda S, Dannals RF, Pomper MG, Horti AG Molecular Imaging and Biology 2017 Apr 19 280-288 -
A PSMA-targeted theranostic agent for photodynamic therapy
Chen Y, Chatterjee S, Lisok A, Minn I, Pullambhatla M, Wharram B, Wang Y, Jin J, Bhujwalla ZM, Nimmagadda S, Mease RC, Pomper MG Journal of Photochemistry and Photobiology B: Biology 2017 Feb 167 111-116 -
MR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused Ultrasound
Airan RD, Foss CA, Ellens NP, Wang Y, Mease RC, Farahani K, Pomper MG Molecular Imaging and Biology 2017 Feb 19 24-30 -
Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis
Kruse MJ, Kovell L, Kasper EK, Pomper MG, Moller DR, Solnes L, Chen ES, Schindler TH JACC: Cardiovascular Imaging 2017 Feb 10 157-167 -
Correlation of PSMA-Targeted 18F-DCFPyL PET/CT Findings With Immunohistochemical and Genomic Data in a Patient With Metastatic Neuroendocrine Prostate Cancer
Tosoian JJ, Gorin MA, Rowe SP, Andreas D, Szabo Z, Pienta KJ, Pomper MG, Lotan TL, Ross AE Clinical Genitourinary Cancer 2017 Feb 15 e65-e68 -
Noninvasive Targeted Transcranial Neuromodulation via Focused Ultrasound Gated Drug Release from Nanoemulsions
Airan RD, Meyer RA, Ellens NP, Rhodes KR, Farahani K, Pomper MG, Kadam SD, Green JJ Nano Letters 2017 Feb 17 652-659 -
Neuroimaging of translocator protein in patients with systemic lupus erythematosus: A pilot study using [11C]DPA-713 positron emission tomography
Wang Y, Coughlin JM, Ma S, Endres CJ, Kassiou M, Sawa A, Dannals RF, Petri M, Pomper MG Lupus 2017 Feb 26 170-178 -
PSMA-Targeted 18F-DCFPyL PET/CT Imaging of Clear Cell Renal Cell Carcinoma: Results from a Rapid Autopsy
Gorin MA, Rowe SP, Hooper JE, Kates M, Hammers HJ, Szabo Z, Pomper MG, Allaf ME European urology 2017 Jan 71 145-146 -
Imaging of glial cell activation and white matter integrity in brains of active and recently retired national football league players
Coughlin JM, Yuchuanwang Y, Minn I, Bienko N, Ambinder EB, Xu X, Peters ME, Dougherty JW, Vranesic M, Koo SM, Ahn HH, Lee M, Cottrell C, Sair HI, Sawa A, Munro CA, Nowinski CJ, Dannals RF, Lyketsos CG, Kassiou M, Smith G, Caffo B, Mori S, Guilarte TR, Pomper MG JAMA neurology 2017 Jan 74 67-74 -
Current Landscape of diaCEST Imaging Agents
Bar-Shir A, Yang X, Song X, Pomper M, McMahon MT 2017 Jan 161-191 -
111In- and IRDye800CW-Labeled PLA-PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues
Banerjee SR, Foss CA, Horhota A, Pullambhatla M, McDonnell K, Zale S, Pomper MG Biomacromolecules 2017 Jan 18 201-209 -
Rapid PD-L1 detection in tumors with PET using a highly specific peptide
Chatterjee S, Lesniak WG, Miller MS, Lisok A, Sikorska E, Wharram B, Kumar D, Gabrielson M, Pomper MG, Gabelli SB, Nimmagadda S Biochemical and Biophysical Research Communications 2017 Jan 483 258-263 -
Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsi
Gorin MA, Marashdeh W, Ross AE, Allaf ME, Pienta KJ, Pomper MG, Rowe SP Nuclear Medicine Communications 2017 38 795-798 -
Development of Radiolabeled Ligands Targeting the Glutamate Binding Site of the N-Methyl-d-aspartate Receptor as Potential Imaging Agents for Brain
Tamborini L, Chen Y, Foss CA, Pinto A, Horti AG, Traynelis SF, De Micheli C, Mease RC, Hansen KB, Conti P, Pomper MG Journal of Medicinal Chemistry 2016 Dec 59 11110-11119 -
Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by 13N-Ammonia Perfusion PET in Patients With Hypertrophic Cardiomyopathy
Yalçin H, Valenta I, Yalçin F, Corona-Villalobos C, Vasquez N, Ra J, Kucukler N, Tahari A, Pozios I, Zhou Y, Pomper M, Abraham TP, Schindler TH, Abraham MR American Journal of Cardiology 2016 Dec 118 1908-1915 -
18F-FNDP for PET Imaging of Soluble Epoxide Hydrolase
Horti AG, Wang Y, Minn I, Lan X, Wang J, Koehler RC, Alkayed NJ, Dannals RF, Pomper MG Journal of Nuclear Medicine 2016 Nov 57 1817-1822 -
Cathepsin B-Specific Metabolic Precursor for In Vivo Tumor-Specific Fluorescence Imaging
Shim MK, Yoon HY, Ryu JH, Koo H, Lee S, Park JH, Kim JH, Lee S, Pomper MG, Kwon IC, Kim K Angewandte Chemie - International Edition 2016 Nov 55 14698-14703 -
Prostate-specific membrane antigen-targeted radiohalogenated PET and therapeutic agents for prostate cancer
Rowe SP, Drzezga A, Neumaier B, Dietlein M, Gorin MA, Zalutsky MR, Pomper MG Journal of Nuclear Medicine 2016 Oct 57 90S-96S -
Development and application of a novel model system to study "active" and "passive" tumor targeting
Mukherjee A, Kumar B, Hatano K, Russell LM, Trock BJ, Searson PC, Meeker AK, Pomper MG, Lupold SE Molecular Cancer Therapeutics 2016 Oct 15 2541-2550 -
(2S)-2-(3-(1-carboxy-5-(4-211At-astatobenzamido)pentyl) ureido)-pentanedioic acid for PSMA-targeted α-particle radiopharmaceutical therapy
Kiess AP, Minn I, Vaidyanathan G, Hobbs RF, Josefsson A, Shen C, Brummet M, Chen Y, Choi J, Koumarianou E, Baidoo K, Brechbiel MW, Mease RC, Sgouros G, Zalutsky MR, Pomper MG Journal of Nuclear Medicine 2016 Oct 57 1569-1575 -
Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation
He QL, Minn I, Wang Q, Xu P, Head SA, Datan E, Yu B, Pomper MG, Liu JO Angewandte Chemie - International Edition 2016 Sep 55 12035-12039 -
Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor
Moldovan RP, Teodoro R, Gao Y, Deuther-Conrad W, Kranz M, Wang Y, Kuwabara H, Nakano M, Valentine H, Fischer S, Pomper MG, Wong DF, Dannals RF, Brust P, Horti AG Journal of Medicinal Chemistry 2016 Sep 59 7840-7855 -
PET imaging of prostate-specific membrane antigen in prostate cancer: Current state of the art and future challenges
Rowe SP, Gorin MA, Allaf ME, Pienta KJ, Tran PT, Pomper MG, Ross AE, Cho SY Prostate Cancer and Prostatic Diseases 2016 Sep 19 223-230 -
PD-L1 Detection in Tumors Using [64Cu]Atezolizumab with PET
Lesniak WG, Chatterjee S, Gabrielson M, Lisok A, Wharram B, Pomper MG, Nimmagadda S Bioconjugate Chemistry 2016 Sep 27 2103-2110 -
An improved synthesis of the radiolabeled prostate-specific membrane antigen inhibitor, [18F]DCFPyL
Ravert HT, Holt DP, Chen Y, Mease RC, Fan H, Pomper MG, Dannals RF Journal of Labelled Compounds and Radiopharmaceuticals 2016 Sep 439-450 -
Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands
Subedi M, Minn I, Chen J, Kim YH, Ok K, Jung YW, Pomper MG, Byun Y European Journal of Medicinal Chemistry 2016 Aug 118 208-218 -
Fluoroethyl Triazole Substituted PSMA Inhibitor Exhibiting Rapid Normal Organ Clearance
Chen Y, Lisok A, Chatterjee S, Wharram B, Pullambhatla M, Wang Y, Sgouros G, Mease RC, Pomper MG Bioconjugate Chemistry 2016 Jul 27 1655-1662 -
Salicylic acid analogues as chemical exchange saturation transfer MRI contrast agents for the assessment of brain perfusion territory and blood-brain barrier opening after intra-arterial infusion
Song X, Walczak P, He X, Yang X, Pearl M, Bulte JW, Pomper MG, McMahon MT, Janowski M Journal of Cerebral Blood Flow and Metabolism 2016 Jul 36 1186-1194 -
Developing imidazoles as CEST MRI pH sensors
Yang X, Song X, Ray Banerjee S, Li Y, Byun Y, Liu G, Bhujwalla ZM, Pomper MG, McMahon MT Contrast Media and Molecular Imaging 2016 Jul 11 304-312 -
Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells
Oh Y, Park O, Swierczewska M, Hamilton JP, Park JS, Kim TH, Lim SM, Eom H, Jo DG, Lee CE, Kechrid R, Mastorakos P, Zhang C, Hahn SK, Jeon OC, Byun Y, Kim K, Hanes J, Lee KC, Pomper MG, Gao B, Lee S Hepatology 2016 Jul 64 209-223 -
Computed tomography appearance of renal hybrid oncocytic/chromophobe tumors
Bhatnagar A, Rowe SP, Gorin MA, Pomper MG, Fishman EK, Allaf ME Journal of computer assisted tomography 2016 Jul 40 513-516 -
Targeted imaging of the atypical chemokine receptor 3 (ACKR3/CXCR7) in human cancer xenografts
Azad BB, Lisok A, Chatterjee S, Poirier JT, Pullambhatla M, Luker GD, Pomper MG, Nimmagadda S Journal of Nuclear Medicine 2016 Jun 57 981-988 -
Preclinical comparative study of 68Ga-labeled DOTA, NOTA, and HBED-CC chelated radiotracers for targeting PSMA
Ray Banerjee S, Chen Z, Pullambhatla M, Lisok A, Chen J, Mease RC, Pomper MG Bioconjugate Chemistry 2016 Jun 27 1447-1455 -
PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
Rowe SP, Macura KJ, Mena E, Blackford AL, Nadal R, Antonarakis ES, Eisenberger M, Carducci M, Fan H, Dannals RF, Chen Y, Mease RC, Szabo Z, Pomper MG, Cho SY Molecular Imaging and Biology 2016 Jun 18 411-419 -
PSMA-targeted imaging of prostate cancer: The best is yet to come
Gorin MA, Pomper MG, Rowe SP BJU international 2016 May 117 715-716 -
[124I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection
Zhang XM, Zhang HH, McLeroth P, Berkowitz RD, Mont MA, Stabin MG, Siegel BA, Alavi A, Barnett TM, Gelb J, Petit C, Spaltro J, Cho SY, Pomper MG, Conklin JJ, Bettegowda C, Saha S Nuclear Medicine and Biology 2016 May 43 273-279 -
In vivo Markers of inflammatory response in recent-onset schizophrenia: A combined study using [11C]DPA-713 PET and analysis of CSF and plasma
Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M, Kim PK, Ford CN, Higgs C, Hayes LN, Schretlen DJ, Dannals RF, Kassiou M, Sawa A, Pomper MG Translational psychiatry 2016 Apr 6 1-8 -
Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatform
Lesniak WG, Oskolkov N, Song X, Lal B, Yang X, Pomper M, Laterra J, Nimmagadda S, McMahon MT Nano Letters 2016 Apr 16 2248-2253 -
Critical Length of PEG Grafts on lPEI/DNA Nanoparticles for Efficient in Vivo Delivery
Williford JM, Archang MM, Minn I, Ren Y, Wo M, Vandermark J, Fisher PB, Pomper MG, Mao HQ ACS Biomaterials Science and Engineering 2016 Apr 2 567-578 -
ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer
You DG, Deepagan VG, Um W, Jeon S, Son S, Chang H, Yoon HI, Cho YW, Swierczewska M, Lee S, Pomper MG, Kwon IC, Kim K, Park JH Scientific reports 2016 Mar 6 -
A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts
Azad BB, Chatterjee S, Lesniak WG, Lisok A, Pullambhatla M, Bhujwalla ZM, Pomper MG, Nimmagadda S Oncotarget 2016 Mar 7 12344-12358 -
PSMA-Based Detection of Prostate Cancer Bone Lesions with 18F-DCFPyL PET/CT: A Sensitive Alternative to 99mTc-MDP Bone Scan and Na18F PET/CT?
Rowe SP, Mana-Ay M, Javadi MS, Szabo Z, Leal JP, Pomper MG, Pienta KJ, Ross AE, Gorin MA Clinical Genitourinary Cancer 2016 Feb 14 e115-e118 -
Characterization of a novel metastatic prostate cancer cell line of LNCaP origin
Castanares MA, Copeland BT, Chowdhury WH, Liu MM, Rodriguez R, Pomper MG, Lupold SE, Foss CA Prostate 2016 Feb 76 215-225 -
PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer
Chen Z, Penet MF, Krishnamachary B, Banerjee SR, Pomper MG, Bhujwalla ZM Biomaterials 2016 Feb 80 57-67 -
A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
Chatterjee S, Lesniak WG, Gabrielson M, Lisok A, Wharram B, Sysa-Shah P, Azad BB, Pomper MG, Nimmagadda S Oncotarget 2016 7 10215-10227 -
Detecting Tumor Metastases: The Road to Therapy Starts Here
Menezes ME, Das SK, Minn I, Emdad L, Wang XY, Sarkar D, Pomper MG, Fisher PB 2016 1-44 -
Ultrahigh affinity Raman probe for targeted live cell imaging of prostate cancer
Li M, Banerjee SR, Zheng C, Pomper MG, Barman I Chemical Science 2016 7 6779-6785 -
TSPO in a murine model of Sandhoff disease: Presymptomatic marker of neurodegeneration and disease pathophysiology
Loth MK, Choi J, McGlothan JL, Pletnikov MV, Pomper MG, Guilarte TR Neurobiology of Disease 2016 Jan 85 174-186 -
Comparison of prostate-specific membrane antigen-based 18F-DCFBC PET/CT to conventional imaging modalities for detection of hormone-naïve and castration-resistant metastatic prostate cancer
Rowe SP, MacUra KJ, Ciarallo A, Mena E, Blackford A, Nadal R, Antonarakis ES, Eisenberger MA, Carducci MA, Ross AE, Kantoff PW, Holt DP, Dannals RF, Mease RC, Pomper MG, Cho SY Journal of Nuclear Medicine 2016 Jan 57 46-53 -
Detection of 18F-FDG PET/CT occult lesions with 18F-DCFPyL PET/CT in a patient with metastatic renal cell carcinoma
Rowe SP, Gorin MA, Hammers HJ, Pomper MG, Allaf ME, Javadi MS Clinical nuclear medicine 2016 Jan 41 83-85 -
Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)
Yang X, Mease RC, Pullambhatla M, Lisok A, Chen Y, Foss CA, Wang Y, Shallal H, Edelman H, Hoye AT, Attardo G, Nimmagadda S, Pomper MG Journal of Medicinal Chemistry 2016 Jan 59 206-218 -
[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
Minn I, Koo SM, Lee HS, Brummet M, Rowe SP, Gorin MA, Sysa-Shah P, Lewis WD, Ahn HH, Wang Y, Banerjee SR, Mease RC, Nimmagadda S, Allaf ME, Pomper MG, Yang X Oncotarget 2016 7 56471-56479 -
Nanoconjugation of PSMA-targeting ligands enhances perinuclear localization and improves efficacy of delivered alpha-particle emitters against tumor endothelial analogues
Zhu C, Bandekar A, Sempkowski M, Banerjee SR, Pomper MG, Bruchertseifer F, Morgenstern A, Sofou S Molecular Cancer Therapeutics 2016 Jan 15 106-113 -
Hyaluronic acid-serum hydrogels rapidly restore metabolism of encapsulated stem cells and promote engraftment
Chan AT, Karakas MF, Vakrou S, Afzal J, Rittenbach A, Lin X, Wahl RL, Pomper MG, Steenbergen CJ, Tsui BM, Elisseeff JH, Abraham MR Biomaterials 2015 Dec 73 1-11 -
A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expression
Meng J, Liu Y, Gao S, Lin S, Gu X, Pomper MG, Wang PC, Shan L Cancer Biology and Therapy 2015 Dec 16 1764-1774 -
Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
Rowe SP, Gorin MA, Hammers HJ, Som Javadi M, Hawasli H, Szabo Z, Cho SY, Pomper MG, Allaf ME Annals of Nuclear Medicine 2015 Dec 29 877-882 -
Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors
Oh Y, Swierczewska M, Kim TH, Lim SM, Eom HN, Park JH, Na DH, Kim K, Lee KC, Pomper MG, Lee S Journal of Controlled Release 2015 Dec 220 671-681 -
Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor
Mishra S, Bedja D, Amuzie C, Foss CA, Pomper MG, Bhattacharya R, Yarema KJ, Chatterjee S Biomaterials 2015 Sep 64 125-135 -
Prostate-specific membrane antigen as a target for cancer imaging and therapy
Kiess AP, Banerjee SR, Mease RC, Rowe SP, Rao A, Foss CA, Chen Y, Yang X, Cho SY, Nimmagadda S, Pomper MG Quarterly Journal of Nuclear Medicine and Molecular Imaging 2015 Sep 59 241-268 -
Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen
Kiess AP, Minn I, Chen Y, Hobbs R, Sgouros G, Mease RC, Pullambhatla M, Shen CJ, Foss CA, Pomper MG Journal of Nuclear Medicine 2015 Sep 56 1401-1407 -
Synthesis and Evaluation of GdIII-Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane Antigen
Banerjee SR, Ngen EJ, Rotz MW, Kakkad S, Lisok A, Pracitto R, Pullambhatla M, Chen Z, Shah T, Artemov D, Meade TJ, Bhujwalla ZM, Pomper MG Angewandte Chemie - International Edition 2015 Sep 54 10778-10782 -
Tumor-specific expression and detection of a CEST reporter gene
Minn I, Bar-Shir A, Yarlagadda K, Bulte JW, Fisher PB, Wang H, Gilad AA, Pomper MG Magnetic resonance in medicine 2015 Aug 74 544-549 -
Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
Szabo Z, Mena E, Rowe SP, Plyku D, Nidal R, Eisenberger MA, Antonarakis ES, Fan H, Dannals RF, Chen Y, Mease RC, Vranesic M, Bhatnagar A, Sgouros G, Cho SY, Pomper MG Molecular Imaging and Biology 2015 Aug 17 565-574 -
18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer
Rowe SP, Gage KL, Faraj SF, Macura KJ, Cornish TC, Gonzalez-Roibon N, Guner G, Munari E, Partin AW, Pavlovich CP, Han M, Carter HB, Bivalacqua TJ, Blackford A, Holt D, Dannals RF, Netto GJ, Lodge MA, Mease RC, Pomper MG, Cho SY Journal of Nuclear Medicine 2015 Jul 56 1003-1010 -
Phosphorus-32, a clinically available drug, inhibits cancer growth by inducing DNA double-strand breakage
Cheng Y, Kiess AP, Herman JM, Pomper MG, Meltzer SJ, Abraham JM PloS one 2015 Jun 10 -
Design and assembly of supramolecular dual-modality nanoprobes
Liu S, Zhang P, Ray Banerjee S, Xu J, Pomper MG, Cui H Nanoscale 2015 Jun 7 9462-9466 -
In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs
Röck R, Bachmann V, Bhang HE, Malleshaiah M, Raffeiner P, Mayrhofer JE, Tschaikner PM, Bister K, Aanstad P, Pomper MG, Michnick SW, Stefan E Scientific reports 2015 Jun 5 -
Cannabinoid CB2 receptors in a mouse model of Aβ amyloidosis: Immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation
Savonenko AV, Melnikova T, Wang Y, Ravert H, Gao Y, Koppel J, Lee D, Pletnikova O, Cho E, Sayyida N, Hiatt A, Troncoso J, Davies P, Dannals RF, Pomper MG, Horti AG PloS one 2015 Jun 10 -
Molecular imaging of inflammation in the ApoE -/- mouse model of atherosclerosis with IodoDPA
Foss CA, Bedja D, Mease RC, Wang H, Kass DA, Chatterjee S, Pomper MG Biochemical and Biophysical Research Communications 2015 May 461 70-75 -
[125I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR
Gao Y, Mease RC, Olson TT, Kellar KJ, Dannals RF, Pomper MG, Horti AG Nuclear Medicine and Biology 2015 May 42 488-493 -
Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates
Banerjee SR, Foss CA, Pullambhatla M, Wang Y, Srinivasan S, Hobbs RF, Baidoo KE, Brechbiel MW, Nimmagadda S, Mease RC, Sgouros G, Pomper MG Journal of Nuclear Medicine 2015 Apr 56 628-634 -
Structural characterization and in vivo evaluation of β-hairpin peptidomimetics as specific CXCR4 imaging agents
Lesniak WG, Sikorska E, Shallal H, Behnam Azad B, Lisok A, Pullambhatla M, Pomper MG, Nimmagadda S Molecular Pharmaceutics 2015 Mar 12 941-953 -
Evaluation of a PSMA-targeted BNF nanoparticle construct
Behnam Azad B, Banerjee SR, Pullambhatla M, Lacerda S, Foss CA, Wang Y, Ivkov R, Pomper MG Nanoscale 2015 Mar 7 4432-4442 -
Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study
Coughlin JM, Wang Y, Munro CA, Ma S, Yue C, Chen S, Airan R, Kim PK, Adams AV, Garcia C, Higgs C, Sair HI, Sawa A, Smith G, Lyketsos CG, Caffo B, Kassiou M, Guilarte TR, Pomper MG Neurobiology of Disease 2015 Feb 74 58-65 -
Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer
Neuman BP, Eifler JB, Castanares M, Chowdhury WH, Chen Y, Mease RC, Ma R, Mukherjee A, Lupold SE, Pomper MG, Rodriguez R Clinical Cancer Research 2015 Feb 21 771-780 -
Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor
Yang X, Minn I, Rowe SP, Banerjee SR, Gorin MA, Brummet M, Lee HS, Koo SM, Sysa-Shah P, Mease RC, Nimmagadda S, Allaf ME, Pomper MG Oncotarget 2015 6 33733-33742 -
Radioiodinated DPA-713 imaging correlates with bactericidal activity of tuberculosis treatments in mice
Ordonez AA, Pokkali S, DeMarco VP, Klunk M, Mease RC, Foss CA, Pomper MG, Jain SK Antimicrobial agents and chemotherapy 2015 Jan 59 642-649 -
Multispectral photoacoustic decomposition with localized regularization for detecting targeted contrast agent
Tavakoli B, Chen Y, Guo X, Kang HJ, Pomper M, Boctor EM 2015 -
Anthranilic acid analogs as diamagnetic CEST MRI contrast agents that feature an intramolecular-bond shifted hydrogen
Song X, Yang X, Ray Banerjee S, Pomper MG, Mcmahon MT Contrast Media and Molecular Imaging 2015 Jan 10 74-80 -
Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia
Coughlin JM, Tanaka T, Marsman A, Wang H, Bonekamp S, Kim PK, Higgs C, Varvaris M, Edden R, Pomper M, Schretlen D, Barker PB, Sawa A Current molecular medicine 2015 15 176-183 -
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype
Wegrzynowicz M, Bichell TJ, Soares BD, Loth MK, McGlothan JL, Alikhan FS, Hua K, Coughlin JM, Holt HK, Jetter CS, Mori S, Pomper MG, Osmand AP, Guilarte TR, Bowman AB Journal of Huntington's disease 2015 4 17-36 -
Tuning phenols with Intra-Molecular bond Shifted HYdrogens (IM-SHY) as diaCEST MRI contrast agents
Yang X, Yadav NN, Song X, Ray Banerjee S, Edelman H, Minn I, van Zijl PC, Pomper MG, McMahon MT Chemistry (Weinheim an der Bergstrasse, Germany) 2014 Nov 20 15824-15832 -
Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA
Yoon HY, Son S, Lee SJ, You DG, Yhee JY, Park JH, Swierczewska M, Lee S, Kwon IC, Kim SH, Kim K, Pomper MG Scientific reports 2014 Nov 4 -
AEG-1 promoter-mediated imaging of prostate cancer
Bhatnagar A, Wang Y, Mease RC, Gabrielson M, Sysa P, Minn I, Green G, Simmons B, Gabrielson K, Sarkar S, Fisher PB, Pomper MG Cancer research 2014 Oct 74 5772-5781 -
Imaging enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography
Weinstein EA, Ordonez AA, DeMarco VP, Murawski AM, Pokkali S, MacDonald EM, Klunk M, Mease RC, Pomper MG, Jain SK Science translational medicine 2014 Oct 6 259ra146 -
Human Brain Imaging of α7 nAChR with [18F]ASEM: a New PET Radiotracer for Neuropsychiatry and Determination of Drug Occupancy
Wong DF, Kuwabara H, Pomper M, Holt DP, Brasic JR, George N, Frolov B, Willis W, Gao Y, Valentine H, Nandi A, Gapasin L, Dannals RF, Horti AG Molecular Imaging and Biology 2014 Oct 16 730-738 -
Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration,and cognitive impairment: Involvement of cell cycle activation
Wu J, Stoica BA, Luo T, Sabirzhanov B, Zhao Z, Guanciale K, Nayar SK, Foss CA, Pomper MG, Faden AI Cell Cycle 2014 Aug 13 2446-2458 -
Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)
Woodard LE, De Silva RA, Behnam Azad B, Lisok A, Pullambhatla M, Lesniak WG, Mease RC, Pomper MG, Nimmagadda S Nuclear Medicine and Biology 2014 Aug 41 552-561 -
State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
Dawidczyk CM, Kim C, Park JH, Russell LM, Lee KH, Pomper MG, Searson PC Journal of Controlled Release 2014 Aug 187 133-144 -
Regional brain distribution of translocator protein using [ 11C]DPA-713 PET in individuals infected with HIV
Coughlin JM, Wang Y, Ma S, Yue C, Kim PK, Adams AV, Roosa HV, Gage KL, Stathis M, Rais R, Rojas C, McGlothan JL, Watkins CC, Sacktor N, Guilarte TR, Zhou Y, Sawa A, Slusher BS, Caffo B, Kassiou M, Endres CJ, Pomper MG Journal of NeuroVirology 2014 Jun 20 219-232 -
Evaluation of prostate-specific membrane antigen as an imaging reporter
Castanares MA, Mukherjee A, Chowdhury WH, Liu M, Chen Y, Mease RC, Wang Y, Rodriguez R, Lupold SE, Pomper MG Journal of Nuclear Medicine 2014 May 55 805-811 -
Structural characterization of P1′-diversified urea-based inhibitors of glutamate carboxypeptidase II
Pavlicek J, Ptacek J, Cerny J, Byun Y, Skultetyova L, Pomper MG, Lubkowski J, Barinka C Bioorganic and Medicinal Chemistry Letters 2014 May 24 2340-2345 -
18F-ASEM, a radiolabeled antagonist for imaging the aα7-nicotinic acetylcholine receptor with PET
Horti AG, Gao Y, Kuwabara H, Wang Y, Abazyan S, Yasuda RP, Tran T, Xiao Y, Sahibzada N, Holt DP, Kellar KJ, Pletnikov MV, Pomper MG, Wong DF, Dannals RF Journal of Nuclear Medicine 2014 Apr 55 672-677 -
A red-shifted fluorescent substrate for aldehyde dehydrogenase
Minn I, Wang H, Mease RC, Byun Y, Yang X, Wang J, Leach SD, Pomper MG Nature communications 2014 Apr 5 -
Sex differences in translocator protein 18 kDa (TSPO) in the heart: Implications for imaging myocardial inflammation
Fairweather DL, Coronado MJ, Garton AE, Dziedzic JL, Bucek A, Cooper LT, Brandt JE, Alikhan FS, Wang H, Endres CJ, Choi J, Pomper MG, Guilarte TR Journal of cardiovascular translational research 2014 Mar 7 192-202 -
64Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer
Banerjee SR, Pullambhatla M, Foss CA, Nimmagadda S, Ferdani R, Anderson CJ, Mease RC, Pomper MG Journal of Medicinal Chemistry 2014 Mar 57 2657-2669 -
Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis
Foerster BR, Carlos RC, Dwamena BA, Callaghan BC, Petrou M, Edden RA, Mohamed MA, Welsh RC, Barker PB, Feldman EL, Pomper MG Annals of Clinical and Translational Neurology 2014 Feb 1 107-114 -
Heterobivalent agents targeting PSMA and integrin- αvβ3
Shallal HM, Minn I, Banerjee SR, Lisok A, Mease RC, Pomper MG Bioconjugate Chemistry 2014 Feb 25 393-405 -
Preface
Pomper MG, Fisher PB Advances in Cancer Research 2014 124 xiii -
Molecular-genetic imaging of cancer
Minn I, Menezes ME, Sarkar S, Yarlagadda K, Das SK, Emdad L, Sarkar D, Fisher PB, Pomper MG 2014 131-169 -
Imaging denatured collagen strands in vivo and Ex vivo via photo-triggered hybridization of caged collagen mimetic peptides
Li Y, Foss CA, Pomper MG, Yu SM Journal of Visualized Experiments 2014 Jan -
Glia and immune cell signaling in bipolar disorder: Insights from neuropharmacology and molecular imaging to clinical application
Watkins CC, Sawa A, Pomper MG Translational psychiatry 2014 Jan 4 -
Imaging Axl expression in pancreatic and prostate cancer xenografts
Nimmagadda S, Pullambhatla M, Lisok A, Hu C, Maitra A, Pomper MG Biochemical and Biophysical Research Communications 2014 Jan 443 635-640 -
Noninvasive molecular imaging of tuberculosis-associated inflammation with radioiodinated DPA-713
Foss CA, Harper JS, Wang H, Pomper MG, Jain SK Journal of Infectious Diseases 2013 Dec 208 2067-2074 -
Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement
Zhou J, Zhu H, Lim M, Blair L, Quinones-Hinojosa A, Messina SA, Eberhart CG, Pomper MG, Laterra J, Barker PB, Van Zijl PC, Blakeley JO Journal of Magnetic Resonance Imaging 2013 Nov 38 1119-1128 -
Detection and localization of carcinoma within the prostate using high resolution transrectal gamma imaging (TRGI) of monoclonal antibody directed at prostate specific membrane antigen (PSMA) - Proof of concept and initial imaging results
Franc BL, Cho SY, Rosenthal SA, Cui Y, Tsui B, Vandewalker KM, Holz AL, Poonamallee U, Pomper MG, James RB European Journal of Radiology 2013 Nov 82 1877-1884 -
Nanoparticles for cancer imaging: The good, the bad, and the promise
Chapman S, Dobrovolskaia M, Farahani K, Goodwin A, Joshi A, Lee H, Meade T, Pomper M, Ptak K, Rao J, Singh R, Sridhar S, Stern S, Wang A, Weaver JB, Woloschak G, Yang L Nano Today 2013 Oct 8 454-460 -
Translational Molecular Imaging of Prostate Cancer
Kiess AP, Cho SY, Pomper MG Current Radiology Reports 2013 Sep 1 216-226 -
Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: A systematic review and individual patient data meta-analysis
Foerster BR, Dwamena BA, Petrou M, Carlos RC, Callaghan BC, Churchill CL, Mohamed MA, Bartels C, Benatar M, Bonzano L, Ciccarelli O, Cosottini M, Ellis CM, Ehrenreich H, Filippini N, Ito M, Kalra S, Melhem ER, Pyra T, Roccatagliata L, Senda J, Sobue G, Turner MR, Feldman EL, Pomper MG Academic radiology 2013 Sep 20 1099-1106 -
Effect of chelators on the pharmacokinetics of 99mTc-labeled imaging agents for the prostate-specific membrane antigen (PSMA)
Ray Banerjee S, Pullambhatla M, Foss CA, Falk A, Byun Y, Nimmagadda S, Mease RC, Pomper MG Journal of Medicinal Chemistry 2013 Aug 56 6108-6121 -
An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-t proton magnetic resonance spectroscopy
Foerster BR, Pomper MG, Callaghan BC, Petrou M, Edden RA, Mohamed MA, Welsh RC, Carlos RC, Barker PB, Feldman EL JAMA neurology 2013 Aug 70 1009-1016 -
Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: An agonist probe for the α7 nicotinic acetylcholine receptor
Ravert HT, Dorff P, Foss CA, Mease RC, Fan H, Holmquist CR, Phillips E, McCarthy DJ, Heys JR, Holt DP, Wang Y, Endres CJ, Dannals RF, Pomper MG Nuclear Medicine and Biology 2013 Aug 40 731-739 -
Focal positive prostate-specific membrane antigen (PSMA) expression in ganglionic tissues associated with prostate neurovascular bundle: Implications for novel intraoperative PSMA-based fluorescent imaging techniques
Chaux A, Eifler J, Karram S, Al-Hussain T, Faraj S, Pomper M, Rodriguez R, Netto GJ Urologic Oncology: Seminars and Original Investigations 2013 Jul 31 572-575 -
Student award winner in the Ph.D. category for the 2013 society for biomaterials annual meeting and exposition, april 10-13, 2013, Boston, Massachusetts: Biomaterial-mediated cancer-specific DNA delivery to liver cell cultures using synthetic poly(beta-amino ester)s
Tzeng SY, Higgins LJ, Pomper MG, Green JJ Journal of Biomedical Materials Research - Part A 2013 Jul 101 A 1837-1845 -
Mix to validate: A facile, reversible pegylation for fast screening of potential therapeutic proteins in vivo
Kim TH, Swierczewska M, Oh Y, Kim A, Jo DG, Park JH, Byun Y, Sadegh-Nasseri S, Pomper MG, Lee KC, Lee S Angewandte Chemie - International Edition 2013 Jul 52 6880-6884 -
Salicylic acid and analogues as diaCEST MRI contrast agents with highly shifted exchangeable proton frequencies
Yang X, Song X, Li Y, Liu G, Ray Banerjee S, Pomper MG, McMahon MT Angewandte Chemie - International Edition 2013 Jul 52 8116-8119 -
Clinical applications of Gallium-68
Banerjee SR, Pomper MG Applied Radiation and Isotopes 2013 Jun 76 2-13 -
Molecular imaging of conscious, unrestrained mice with AwakeSPECT
Baba JS, Endres CJ, Foss CA, Nimmagadda S, Jung H, Goddard JS, Lee S, McKisson J, Smith MF, Stolin AV, Weisenberger AG, Pomper MG Journal of Nuclear Medicine 2013 Jun 54 969-976 -
Synthesis and biological evaluation of substrate-based imaging agents for the prostate-specific membrane antigen
Byun Y, Pullambhatla M, Wang H, Mease RC, Pomper MG Macromolecular Research 2013 May 21 565-573 -
Subcortical dopaminergic deficits in a DISC1 mutant model: A study in direct reference to human molecular brain imaging
Jaaro-Peled H, Niwa M, Foss CA, Murai R, Reyes Sd, Kamiya A, Mateo Y, O'Donnell P, Cascella NG, Nabeshima T, Guilarte TR, Pomper MG, Sawa A Human molecular genetics 2013 Apr 22 1574-1580 -
Cellular bioenergetics is an important determinant of the molecular imaging signal derived from luciferase and the sodium-iodide symporter
Chang C, Chan A, Lin X, Higuchi T, Terrovitis J, Afzal JM, Rittenbach A, Sun D, Vakrou S, Woldemichael K, O'Rourke B, Wahl R, Pomper M, Tsui B, Abraham MR Circulation research 2013 Feb 112 441-450 -
Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia
Coughlin JM, Ishizuka K, Kano SI, Edwards JA, Seifuddin FT, Shimano MA, Daley EL, Zandi PP, Leweke FM, Cascella NG, Pomper MG, Yolken RH, Sawa A Molecular psychiatry 2013 Jan 18 10-11 -
PET imaging in prostate cancer: Focus on prostate-specific membrane antigen
Mease RC, Foss CA, Pomper MG Current topics in medicinal chemistry 2013 13 951-962 -
Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expression
Bar-Shir A, Liu G, Liang Y, Yadav NN, McMahon MT, Walczak P, Nimmagadda S, Pomper MG, Tallman KA, Greenberg MM, Van Zijl PC, Bulte JW, Gilad AA Journal of the American Chemical Society 2013 Jan 135 1617-1624 -
SYnthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen
Chen Y, Pullambhatla M, Banerjee. SR, Byun Y, Stathis M, Rojas C, Slusher BS, Mease RC, Pomper MG Bioconjugate Chemistry 2012 Dec 23 2377-2385 -
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis
Rahn KA, Watkins CC, Alt J, Rais R, Stathis M, Grishkan I, Crainiceau CM, Pomper MG, Rojas C, Pletnikov MV, Calabresi PA, Brandt J, Barker PB, Slusher BS, Kaplin AI Proceedings of the National Academy of Sciences of the United States of America 2012 Dec 109 20101-20106 -
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer
Cho SY, Gage KL, Mease RC, Senthamizhchelvan S, Holt DP, Jeffrey-Kwanisai A, Endres CJ, Dannals RF, Sgouros G, Lodge M, Eisenberger MA, Rodriguez R, Carducci MA, Rojas C, Slusher BS, Kozikowski AP, Pomper MG Journal of Nuclear Medicine 2012 Dec 53 1883-1891 -
Influence of bioluminescence imaging dynamics by dluciferin uptake and efflux mechanisms
Zhang Y, Pullambhatla M, Laterra J, Pomper MG Molecular Imaging 2012 Nov 11 499-506 -
Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation
Sagar D, Lamontagne A, Foss CA, Khan ZK, Pomper MG, Jain P Journal of Neuroinflammation 2012 Oct 9 -
Targeting collagen strands by photo-triggered triple-helix hybridization
Li Y, Foss CA, Summerfield DD, Doyle JJ, Torok CM, Dietz HC, Pomper MG, Yu SM Proceedings of the National Academy of Sciences of the United States of America 2012 Sep 109 14767-14772 -
Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase II
Alquicer G, Sedlák D, Byun Y, Pavlíček J, Stathis M, Rojas C, Slusher B, Pomper MG, Bartůněk P, Bařinka C Journal of Biomolecular Screening 2012 Sep 17 1030-1040 -
PSMA-targeted theranostic nanoplex for prostate cancer therapy
Chen Z, Penet MF, Nimmagadda S, Li C, Banerjee SR, Winnard PT, Artemov D, Glunde K, Pomper MG, Bhujwalla ZM ACS Nano 2012 Sep 6 7752-7762 -
Theranostic imaging of cancer
Penet MF, Chen Z, Kakkad S, Pomper MG, Bhujwalla ZM European Journal of Radiology 2012 Sep 81 S124-S126 -
Diagnostic Accuracy Using Diffusion Tensor Imaging in the Diagnosis of ALS. A Meta-analysis
Foerster BR, Dwamena BA, Petrou M, Carlos RC, Callaghan BC, Pomper MG Academic radiology 2012 Sep 19 1075-1086 -
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
Krishnamachary B, Penet MF, Nimmagadda S, Mironchik Y, Raman V, Solaiyappan M, Semenza GL, Pomper MG, Bhujwalla ZM PloS one 2012 Aug 7 -
Ovarian cancer gene therapy using HPV-16 Pseudovirion carrying the HSV-tk gene
Hung CF, Chiang AJ, Tsai HH, Pomper MG, Kang TH, Roden RR, Wu TC PloS one 2012 Jul 7 -
Decreased microglial activation in MS patients treated with glatiramer acetate
Ratchford JN, Endres CJ, Hammoud DA, Pomper MG, Shiee N, McGready J, Pham DL, Calabresi PA Journal of neurology 2012 Jun 259 1199-1205 -
[32P]ATP inhibits the growth of xenografted tumors in nude mice
Cheng Y, Senthamizhchelvan S, Agarwal R, Green GM, Mease RC, Sgouros G, Huso DL, Pomper MG, Meltzer SJ, Abraham JM Cell Cycle 2012 May 11 1878-1882 -
Cancer imaging: Gene transcription-based imaging and therapeutic systems
Bhang HE, Pomper MG International Journal of Biochemistry and Cell Biology 2012 May 44 684-689 -
GCPII imaging and cancer
Foss CA, Mease RC, Cho SY, Kim HJ, Pomper MG Current Medicinal Chemistry 2012 Mar 19 1346-1359 -
Mechanisms of dendritic cell trafficking across the blood-brain barrier
Sagar D, Foss C, El Baz R, Pomper MG, Khan ZK, Jain P Journal of Neuroimmune Pharmacology 2012 Mar 7 74-94 -
Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer
Bařinka C, Rojas C, Slusher B, Pomper M Current Medicinal Chemistry 2012 Feb 19 856-870 -
Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions
Harper J, Skerry C, Davis SL, Tasneen R, Weir M, Kramnik I, Bishai WR, Pomper MG, Nuermberger EL, Jain SK Journal of Infectious Diseases 2012 Feb 205 595-602 -
Radiation dosimetry and biodistribution of the TSPO ligand 11C-DPA-713 in humans
Endres CJ, Coughlin JM, Gage KL, Watkins CC, Kassiou M, Pomper MG Journal of Nuclear Medicine 2012 Feb 53 330-335 -
Imaging Infection Based on Expression of Thymidine Kinase
Bettegowda C, Byun Y, Foss CA, Sgouros G, Ambinder RF, Pomper MG 2012 Jan 175-200 -
Clinical translation of molecular imaging probes
Cho SY, Pomper MG 2012 Jan 1041-1065 -
Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules
Hedvat M, Emdad L, Das SK, Kim K, Dasgupta S, Thomas S, Hu B, Zhu S, Dash R, Quinn BA, Oyesanya RA, Kegelman TP, Sokhi UK, Sarkar S, Erdogan E, Menezes ME, Bhoopathi P, Wang XY, Pomper MG, Wei J, Wu B, Stebbins JL, Diaz PW, Reed JC, Pellecchia M, Sarkar D, Fisher PB Anti-Cancer Agents in Medicinal Chemistry 2012 12 1143-1155 -
Novel parametric PET image quantification using texture and shape analysis
Rahmim A, Coughlin J, Gonzalez M, Endres CJ, Zhou Y, Wong DF, Wahl RL, Sossi V, Pomper MG 2012 2227-2230 -
2-(3-{1-carboxy-5-[(6-[ 18F]fluoro-pyridine-3-carbonyl)-amino]- pentyl}-ureido)-pentanedioic acid, [ 18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer
Chen Y, Pullambhatla M, Foss CA, Byun Y, Nimmagadda S, Senthamizhchelvan S, Sgouros G, Mease RC, Pomper MG Clinical Cancer Research 2011 Dec 17 7645-7653 -
A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA)
Banerjee SR, Pullambhatla M, Shallal H, Lisok A, Mease RC, Pomper MG Oncotarget 2011 Dec 2 1244-1253 -
Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity
Plechanovová A, Byun Y, Alquicer G, Škultétyová L, Mlčochová P, Němcová A, Kim HJ, Navrátil M, Mease R, Lubkowski J, Pomper M, Konvalinka J, Rulíšek L, Bařinka C Journal of Medicinal Chemistry 2011 Nov 54 7535-7546 -
CuInSe/ZnS core/shell NIR quantum dots for biomedical imaging
Park J, Dvoracek C, Lee KH, Galloway JF, Bhang HE, Pomper MG, Searson PC Small 2011 Nov 7 3148-3152 -
Metabolic signatures imaged in cancer-induced cachexia
Penet MF, Gadiya MM, Krishnamachary B, Nimmagadda S, Pomper MG, Artemov D, Bhujwalla ZM Cancer research 2011 Nov 71 6948-6956 -
Probing in vivo trafficking of polymer/DNA micellar nanoparticles using SPECT/CT imaging
Patil RR, Yu J, Banerjee SR, Ren Y, Leong D, Jiang X, Pomper M, Tsui B, Kraitchman DL, Mao HQ Molecular Therapy 2011 Sep 19 1626-1635 -
Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen
Banerjee SR, Pullambhatla M, Byun Y, Nimmagadda S, Foss CA, Green G, Fox JJ, Lupold SE, Mease RC, Pomper MG Angewandte Chemie - International Edition 2011 Sep 50 9167-9170 -
Effects of recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of 18f-fluorodeoxyglucose and radioiodide
Reinfelder J, Maschauer S, Foss CA, Nimmagadda S, Fremont V, Wolf V, Weintraub BD, Pomper MG, Szkudlinski MW, Kuwert T, Prante O Thyroid 2011 Jul 21 783-792 -
Strong inhibition of xenografted tumor growth by low-level doses of [32P]ATP
Cheng Y, Yang J, Agarwal R, Green GM, Mease RC, Pomper MG, Meltzer SJ, Abraham JM Oncotarget 2011 Jun 2 461-466 -
A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy
Hobbs RF, Baechler S, Fu DX, Esaias C, Pomper MG, Ambinder RF, Sgouros G Medical physics 2011 Jun 38 2892-2903 -
Imaging CXCR4 expression in human cancer xenografts: Evaluation of monocyclam64Cu-AMD3465
De Silva RA, Peyre K, Pullambhatla M, Fox JJ, Pomper MG, Nimmagadda S Journal of Nuclear Medicine 2011 Jun 52 986-993 -
High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S)
Wilson BA, Wang H, Nacev BA, Mease RC, Liu JO, Pomper MG, Isaacs WB Molecular Cancer Therapeutics 2011 May 10 825-838 -
Myocardial substrate and route of administration determine acute cardiac retention and lung biodistribution of cardiosphere-derived cells
Bonios M, Terrovitis J, Chang CY, Engles JM, Higuchi T, Lautamäki R, Yu J, Fox J, Pomper M, Wahl RL, Tsui BM, O'Rourke B, Bengel FM, Marbán E, Abraham MR Journal of Nuclear Cardiology 2011 May 18 443-450 -
Reference tissue modeling with parameter coupling: Application to a study of SERT binding in HIV
Endres CJ, Hammoud DA, Pomper MG Physics in medicine and biology 2011 Apr 56 2499-2513 -
The evolution of imaging in cancer: Current state and future challenges
Higgins LJ, Pomper MG Seminars in oncology 2011 Feb 38 3-15 -
Progressive multifocal leukoencephalopathy
Barker PB, Pomper M 2011 Jan 518 -
Compact CdZnTe-based gamma camera for prostate cancer imaging
Cui Y, Lall T, Tsui B, Yu J, Mahler G, Bolotnikov A, Vaska P, De Geronimo G, O'Connor P, Meinken G, Joyal J, Barrettf J, Camarda G, Hossain A, Kim KH, Yang G, Pomper M, Cho S, Weisman K, Seo Y, Babich J, LaFrance N, James RB 2011 -
A robust approach to enhance tumor-selective accumulation of nanoparticles
Qiao Y, Huang X, Nimmagadda S, Bai R, Staedtke V, Foss CA, Cheong I, Holdhoff M, Kato Y, Pomper MG, Riggins GJ, Kinzler KW, Diaz LA, Vogelstein B, Zhou S Oncotarget 2011 2 59-68 -
Continuing Education Course #1:Non-Invasive Imaging as a Problem-Solving Tool and Translational Biomarker Strategy in Toxicologic Pathology
Peterson RA, Gabrielson KL, Allan Johnson G, Pomper MG, Coatney RW, Winkelmann CT Toxicologic Pathology 2011 Jan 39 267-272 -
Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression
Bhang HE, Gabrielson KL, Laterra J, Fisher PB, Pomper MG Nature medicine 2011 Jan 17 123-129 -
Tumefactive multiple sclerosis
Barker PB, Pomper M 2011 Jan 315 -
Effect of nitroxoline on angiogenesis and growth of human bladder cancer
Shim JS, Matsui Y, Bhat S, Nacev BA, Xu J, Bhang HE, Dhara S, Han KC, Chong CR, Pomper MG, So A, Liu JO Journal of the National Cancer Institute 2010 Dec 102 1855-1873 -
Experimental evaluation of depth-of-interaction correction in a small-animal positron emission tomography scanner
Green MV, Ostrow HG, Seidel J, Pomper MG Molecular Imaging 2010 Nov 9 311-318 -
Brain metabolism and cognitive impairment in HIV infection: A 3-T magnetic resonance spectroscopy study
Mohamed MA, Barker PB, Skolasky RL, Selnes OA, Moxley RT, Pomper MG, Sacktor NC Magnetic Resonance Imaging 2010 Nov 28 1251-1257 -
Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection
Lentz MR, Degaonkar M, Mohamed MA, Kim H, Conant K, Halpern EF, Sacktor N, Barker PB, Pomper MG Journal of NeuroVirology 2010 Oct 16 368-376 -
Improved syntheses of precursors for PET radioligands [18F]XTRA and [18F]AZAN
Gao Y, Wang H, Mease RC, Pomper MG, Horti AG Tetrahedron Letters 2010 Oct 51 5333-5335 -
68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer
Banerjee SR, Pullambhatla M, Byun Y, Nimmagadda S, Green G, Fox JJ, Horti A, Mease RC, Pomper MG Journal of Medicinal Chemistry 2010 Jul 53 5333-5341 -
Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma
Joyal JL, Barrett JA, Marquis JC, Chen J, Hillier SM, Maresca KP, Boyd M, Gage K, Nimmagadda S, Kronauge JF, Friebe M, Dinkelborg L, Stubbs JB, Stabin MG, Mairs R, Pomper MG, Babich JW Cancer research 2010 May 70 4045-4053 -
Molecular imaging: Techniques and current clinical applications
Bonekamp D, Hammoud DA, Pomper MG Applied Radiology 2010 May 39 10-21 -
Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography
Nimmagadda S, Pullambhatla M, Stone K, Green G, Bhujwalla ZM, Pomper MG Cancer research 2010 May 70 3935-3944 -
Positron emission tomography for serial imaging of the contused adult rat spinal cord
Tewarie RD, Yu J, Seidel J, Rahiem ST, Hurtado A, Tsui BM, Grotenhuis JA, Pomper MG, Oudega M Molecular Imaging 2010 Mar 9 108-116 -
Factor analysis of proton MR spectroscopic imaging data in HIV infection: Metabolite-derived factors help identify infection and dementia
Mohamed MA, Lentz MR, Lee V, Halpern EF, Sacktor N, Selnes O, Barker PB, Pomper MG RADIOLOGY 2010 Feb 254 577-586 -
Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV
Hammoud DA, Endres CJ, Hammond E, Uzuner O, Brown A, Nath A, Kaplin AI, Pomper MG NeuroImage 2010 Feb 49 2588-2595 -
Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies
Wang H, Byun Y, Barinka C, Pullambhatla M, Bhang He, Fox JJ, Lubkowski J, Mease RC, Pomper MG Bioorganic and Medicinal Chemistry Letters 2010 Jan 20 392-397 -
Magnetic resonance imaging features of pituicytomas: Analysis of 10 cases
Hammoud DA, Munter FM, Brat DJ, Pomper MG Journal of computer assisted tomography 2010 34 757-761 -
A low molecular weight PSMA-based fluorescent imaging agent for cancer
Chen Y, Dhara S, Banerjee SR, Byun Y, Pullambhatla M, Mease RC, Pomper MG Biochemical and Biophysical Research Communications 2009 Dec 390 624-629 -
Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment
Davis SL, Nuermberger EL, Um PK, Vidal C, Jedynak B, Pomper MG, Bishai WR, Jain SK Antimicrobial agents and chemotherapy 2009 Nov 53 4879-4884 -
Recent Development of Diagnostic and Therapeutic Agents Targeting Glutamate Carboxypeptidase II (GCPII)
Byun Y, Mease RC, Lupold SE, Pomper MG 2009 Nov 881-910 -
Synthesis of [125I]iodoDPA-713: A new probe for imaging inflammation
Wang H, Pullambhatla M, Guilarte TR, Mease RC, Pomper MG Biochemical and Biophysical Research Communications 2009 Nov 389 80-83 -
Noninvasive Quantification and Optimization of Acute Cell Retention by In Vivo Positron Emission Tomography After Intramyocardial Cardiac-Derived Stem Cell Delivery
Terrovitis J, Lautamäki R, Bonios M, Fox J, Engles JM, Yu J, Leppo MK, Pomper MG, Wahl RL, Seidel J, Tsui BM, Bengel FM, Abraham MR, Marbán E Journal of the American College of Cardiology 2009 Oct 54 1619-1626 -
New agents and techniques for imaging prostate cancer
Zaheer A, Cho SY, Pomper MG Journal of Nuclear Medicine 2009 Sep 50 1387-1390 -
Letter to the Editor
Pomper MG Seminars in Nuclear Medicine 2009 Sep 39 354 -
Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer
Hillier SM, Maresca KP, Femia FJ, Marquis JC, Foss CA, Nguyen N, Zimmerman CN, Barrett JA, Eckelman WC, Pomper MG, Joyal JL, Babich JW Cancer research 2009 Sep 69 6932-6940 -
Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans
Endres CJ, Pomper MG, James M, Uzuner O, Hammoud DA, Watkins CC, Reynolds A, Hilton J, Dannals RF, Kassiou M Journal of Nuclear Medicine 2009 Aug 50 1276-1282 -
EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts
Lal B, Goodwin CR, Sang Y, Foss CA, Cornet K, Muzamil S, Pomper MG, Kim J, Laterra J Molecular Cancer Therapeutics 2009 Jul 8 1751-1760 -
Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT
Nimmagadda S, Pullambhatla M, Pomper MG Journal of Nuclear Medicine 2009 Jul 50 1124-1130 -
Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals
Davis SL, Be NA, Lamichhane G, Nimmagadda S, Pomper MG, Bishai WR, Jain SK PloS one 2009 Jul 4 -
Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer
LeBeau AM, Banerjee SR, Pomper MG, Mease RC, Denmeade SR Bioorganic and Medicinal Chemistry 2009 Jul 17 4888-4893 -
Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay
Zhang Y, Byun Y, Ren YR, Liu JO, Laterra J, Pomper MG Cancer research 2009 Jul 69 5867-5875 -
[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy
Ma WW, Jacene H, Song D, Vilardell F, Messersmith WA, Laheru D, Wahl R, Endres C, Jimeno A, Pomper MG, Hidalgo M Journal of Clinical Oncology 2009 Jun 27 2697-2704 -
Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells
Nimmagadda S, Glunde K, Pomper MG, Bhujwalla ZM Neoplasia 2009 May 11 477-484 -
Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models
Pomper MG, Hammond H, Yu X, Ye Z, Foss CA, Lin DD, Fox JJ, Cheng L Cell Research 2009 Mar 19 370-379 -
Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp
Zhang Y, Laterra J, Pomper MG Neoplasia 2009 Jan 11 96-101 -
Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: Structural characterization
Barinka C, Byun Y, Dusich CL, Banerjee SR, Chen Y, Castanares M, Kozikowski AP, Mease RC, Pomper MG, Lubkowski J Journal of Medicinal Chemistry 2008 Dec 51 7737-7743 -
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer
Chen Y, Foss CA, Byun Y, Nimmagadda S, Pullambhatla M, Fox JJ, Castanares M, Lupold SE, Babich JW, Mease RC, Pomper MG Journal of Medicinal Chemistry 2008 Dec 51 7933-7943 -
Ectopic Expression of the Sodium-Iodide Symporter Enables Imaging of Transplanted Cardiac Stem Cells In Vivo by Single-Photon Emission Computed Tomography or Positron Emission Tomography
Terrovitis J, Kwok KF, Lautamäki R, Engles JM, Barth AS, Kizana E, Miake J, Leppo MK, Fox J, Seidel J, Pomper M, Wahl RL, Tsui B, Bengel F, Marbán E, Abraham MR Journal of the American College of Cardiology 2008 Nov 52 1652-1660 -
Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging
Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, Van Zijl PC Magnetic resonance in medicine 2008 Oct 60 842-849 -
Molecular imaging in prostate cancer
Cho SY, Pomper MG 2008 Oct 623-643 -
Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors
Fu DX, Tanhehco Y, Chen J, Foss CA, Fox JJ, Chong JM, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, Pomper MG, Ambinder RF Nature medicine 2008 Oct 14 1118-1122 -
Molecular Imaging in Oncology
Pomper M, Gelovani JG 2008 Oct -
Preface
Pomper M 2008 Oct ix -
Imaging virus-associated cancer
Fu DX, Foss CA, Nimmagadda S, Ambinder RF, Pomper MG Current Pharmaceutical Design 2008 Oct 14 3048-3065 -
An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer
Song H, Shahverdi K, Huso DL, Wang Y, Fox JJ, Hobbs RF, Gimi B, Gabrielson KL, Pomper MG, Tsui BM, Bhujwalla Z, Reilly RT, Sgouros G Clinical Cancer Research 2008 Oct 14 6116-6124 -
Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)
Banerjee SR, Foss CA, Castanares M, Mease RC, Byun Y, Fox JJ, Hilton J, Lupold SE, Kozikowski AP, Pomper MG Journal of Medicinal Chemistry 2008 Aug 51 4504-4517 -
Spatio-temporal modification of collagen scaffolds mediated by triple helical propensity
Wang AY, Foss CA, Leong S, Mo X, Pomper MG, Yu SM Biomacromolecules 2008 Jul 9 1755-1763 -
In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the rat
Tipre DN, Fox JJ, Holt DP, Green G, Yu J, Pomper M, Dannals RF, Bengel FM Journal of Nuclear Medicine 2008 Jul 49 1189-1195 -
Molecular imaging: the future of modern medicine.
Conti PS, McEwan AJ, Pomper MG Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008 Jun 49 16N-20N -
Molecular imaging of metastatic potential
Winnard PT, Pathak AP, Dhara S, Cho SY, Raman V, Pomper MG Journal of Nuclear Medicine 2008 Jun 49 96S-112S -
Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA)
Chandran SS, Banerjee SR, Mease RC, Pomper MG, Denmeade SR Cancer Biology and Therapy 2008 Jun 7 974-982 -
Antibiotic treatment of tuberculosis: Old problems, new solutions
Jain SK, Lamichhane G, Nimmagadda S, Pomper MG, Bishai WR Microbe 2008 Jun 3 285-292 -
N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L- cysteine, [18F]DCFBC: A new Imaging probe for prostate cancer
Mease RC, Dusich CL, Foss CA, Ravert HT, Dannals RF, Seidel J, Prideaux A, Fox JJ, Sgouros G, Kozikowski AP, Pomper MG Clinical Cancer Research 2008 May 14 3036-3043 -
Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin v single-photon emission computed tomography
Gabrielson KL, Mok GS, Nimmagadda S, Bedja D, Pin S, Tsao A, Wang Y, Sooryakumar D, Yu SJ, Pomper MG, Tsui BM Molecular Imaging 2008 May 7 132-138 -
Targeted Molecular Imaging in Oncology: Focus on Radiation Therapy
Nimmagadda S, Ford EC, Wong JW, Pomper MG Seminars in Radiation Oncology 2008 Apr 18 136-148 -
Dysregulation of glutamate carboxypeptidase II in psychiatric disease
Guilarte TR, Hammoud DA, McGlothan JL, Caffo BS, Foss CA, Kozikowski AP, Pomper MG Schizophrenia Research 2008 Feb 99 324-332 -
Evaluation of human brain tumor heterogeneity using multiple T 1-based MRI signal weighting approaches
Donahue MJ, Blakeley JO, Zhou J, Pomper MG, Laterra J, Van Zijl PC Magnetic resonance in medicine 2008 Feb 59 336-344 -
Awake animal SPECT: Overview and initial results
Weisenberger AG, Kross B, Majewski S, McKisson J, Popov V, Proffitt J, Stolin A, Baba JS, Goddard JS, Lee SJ, Smith MF, Tsui B, Pomper M 2008 5588-5591 -
Characterization of membrane potential-dependent uptake of the novel PET tracer 18F-fluorobenzyl triphenylphosphonium cation
Madar I, Ravert H, Nelkin B, Abro M, Pomper M, Dannals R, Frost JJ European Journal of Nuclear Medicine and Molecular Imaging 2007 Dec 34 2057-2065 -
Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT
Diaz LA, Foss CA, Thornton K, Nimmagadda S, Endres CJ, Uzuner O, Seyler TM, Ulrich SD, Conway J, Bettegowda C, Agrawal N, Cheong I, Zhang X, Ladenson PW, Vogelstein BN, Mont MA, Zhou S, Kinzler KW, Vogelstein B, Pomper MG PloS one 2007 Oct 2 -
ABCG2/BCRP expression modulates D-luciferin-based bioluminescence imaging
Zhang Y, Bressler JP, Neal J, Lal B, Bhang HE, Laterra J, Pomper MG Cancer research 2007 Oct 67 9389-9397 -
Molecular neuroimaging: From conventional to emerging techniques
Hammoud DA, Hoffman JM, Pomper MG RADIOLOGY 2007 Oct 245 21-42 -
New techniques for imaging human immunodeficiency virus-associated cognitive impairment in the era of highly active antiretroviral therapy
Pomper MG, Sacktor N Archives of neurology 2007 Sep 64 1233-1235 -
FDG-PET for pharmacodynamic assessment of the fatty acid synthase inhibitor C75 in an experimental model of lung cancer
Lee JS, Orita H, Gabrielson K, Alvey S, Hagemann RL, Kuhajda FP, Gabrielson E, Pomper MG Pharmaceutical Research 2007 Jun 24 1202-1207 -
TH‐C‐L100J‐09: Noninvasive Evaluation of Early Radiation‐Induced Pulmonary Inflammation Via [11C]‐PK11195 Based PET Imaging
Liu Z, Armour E, Ford E, Pomper M, Wong J Medical physics 2007 Jun 34 2623 -
In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla
Edden RA, Pomper MG, Barker PB Magnetic resonance in medicine 2007 Jun 57 977-982 -
Letter to the editor [5]
Pomper MG, Solomon SB Journal of Neuro-Oncology 2007 May 82 329 -
Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: Initial imaging in experimental models of pancreatic cancer
Foss CA, Fox JJ, Feldmann G, Maitra A, Iacobuzio-Donohue C, Kern SE, Hruban R, Pomper MG Molecular Imaging 2007 Mar 6 131-139 -
Virus-associated tumor imaging by induction of viral gene expression
Fu DX, Tanhehco YC, Chen J, Foss CA, Fox JJ, Lemas V, Chong JM, Ambinder RF, Pomper MG Clinical Cancer Research 2007 Mar 13 1453-1458 -
Experimental evaluation of the bilinear transformation used in the CT-based attenuation correction for small animal PET imaging
Jianhua Y, Seidel J, Pomper M, Tsui BM 2007 3747-3750 -
Validation of GATE Monte Carlo simulation of the performance characteristics of a GE eXplore VISTA small animal PET system
Yang CC, Seidel J, Wang Y, Lee JS, Pomper MG, Tsui BM 2007 3187-3190 -
Workshop on imaging science development for cancer prevention and preemption
Kelloff GJ, Sullivan DC, Baker H, Clarke LP, Nordstrom R, Tatum JL, Dorfman GS, Jacobs P, Berg CD, Pomper MG, Birrer MJ, Tempero M, Higley HR, Petty BG, Sigman CC, Maley C, Sharma P, Wax A, Ginsberg GG, Dannenberg AJ, Hawk ET, Messing EM, Grossman HB, Harisinghani M, Bigio IJ, Griebel D, Henson DE, Fabian CJ, Ferrara K, Fantini S, Schnall MD, Zujewski JA, Hayes W, Klein EA, DeMarzo A, Ocak I, Ketterling JA, Tempany C, Shtern F, Parnes HL, Gomez J, Srivastava S, Szabo E, Lam S, Seibel EJ, Massion P, McLennan G, Cleary K, Suh R, Burt RW, Pfeiffer RM, Hoffman JM, Roy HK, Wang T, Limburg PJ, El-Deiry WS, Papadimitrakopoulou V, Hittelman WN, MacAulay C, Veltri RW, Solomonzz D, Jeronimo J, Richards-Kortum R, Johnson KA, Viner JL, Stratton SP, Rajadhyaksha M, Dhawan A Cancer Biomarkers 2007 3 1-33 -
Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner
Wang Y, Seidel J, Tsui BM, Vaquero JJ, Pomper MG Journal of Nuclear Medicine 2006 Nov 47 1891-1900 -
Amide proton transfer imaging of human brain tumors at 3T
Jones CK, Schlosser MJ, Van Zijl PC, Pomper MG, Golay X, Zhou J Magnetic resonance in medicine 2006 Sep 56 585-592 -
Synthesis of [11C]gefitinib for imaging epidermal growth factor receptor tyrosine kinase with positron emission tomography
Holt DP, Ravert HT, Dannals RF, Pomper MG, Morgan RH Journal of Labelled Compounds and Radiopharmaceuticals 2006 Sep 49 883-888 -
Proton MR spectroscopy in hyperhomocysteinemia with elevated blood methionine levels
Franco LP, Anderson J, Okoh J, Pomper MG, Braverman N, Barker PB Journal of Magnetic Resonance Imaging 2006 Mar 23 404-407 -
Central nervous system imaging
Hammoud DA, Pomper MG 2006 369-380 -
Instrumentation development of a SPECT-CT system to image awake mice
Weisenberger AG, Kross B, Majewski S, Popov V, Smith MF, Tran VH, Welch B, Baba J, Goddard J, Pomper M, Tsui B 2006 3000-3003 -
NAAG peptidase inhibitors and their potential for diagnosis and therapy
Zhou J, Neale JH, Pomper MG, Kozikowski AP Nature Reviews Drug Discovery 2005 Dec 4 1015-1026 -
Pharmacologic and toxicologic evaluation of C. novyi-NT spores
Diaz LA, Cheong I, Foss CA, Zhang X, Peters BA, Agrawal N, Bettegowda C, Karim B, Liu G, Khan K, Huang X, Kohli M, Dang LH, Hwang P, Vogelstein A, Garrett-Mayer E, Kobrin B, Pomper M, Zhou S, Kinzler KW, Vogelstein B, Huso DL Toxicological Sciences 2005 Dec 88 562-575 -
Glutamate carboxypeptidase II levels in rodent brain using [ 125I]DCIT quantitative autoradiography
Guilarte TR, McGlothan JL, Foss CA, Zhou J, Heston WD, Kozikowski AP, Pomper MG Neuroscience letters 2005 Oct 387 141-144 -
In vivo imaging of peripheral benzodiazepine receptors in mouse lungs: A biomarker of inflammation
Hardwick MJ, Chen MK, Baidoo K, Pomper MG, Guilarte TR Molecular Imaging 2005 Oct 4 432-438 -
Synthesis and biodistribution of 11C-GW7845, a positron-emitting agonist for peroxisome proliferator-activated receptor-γ
Mathews WB, Foss CA, Stoermer D, Ravert HT, Dannals RF, Henke BR, Pomper MG Journal of Nuclear Medicine 2005 Oct 46 1719-1726 -
Quantitative proton magnetic resonance spectroscopic imaging: Regional variations in the corpus callosum and cortical gray matter
Degaonkar MN, Pomper MG, Barker PB Journal of Magnetic Resonance Imaging 2005 Aug 22 175-179 -
Autoimmune hypophysitis
Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR Endocrine reviews 2005 Aug 26 599-614 -
Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS
Hammoud DA, Endres CJ, Chander AR, Guilarte TR, Wong DF, Sacktor NC, McArthur JC, Pomper MG Journal of NeuroVirology 2005 Aug 11 346-355 -
Routine clinical brain MRI sequences for use at 3.0 tesla
Lu H, Nagae-Poetscher LM, Golay X, Lin D, Pomper M, Van Zijl PC Journal of Magnetic Resonance Imaging 2005 Jul 22 13-22 -
Radiolabeled small-molecule ligands for prostate-specific membrane antigen: In vivo imaging in experimental models of prostate cancer
Foss CA, Mease RC, Fan H, Wang Y, Ravert HT, Dannals RF, Olszewski RT, Heston WD, Kozikowski AP, Pomper MG Clinical Cancer Research 2005 Jun 11 4022-4028 -
A restraint-free small animal SPECT imaging system with motion tracking
Weisenberger AG, Gleason SS, Goddard J, Kross B, Majewski S, Meikle SR, Paulus MJ, Pomper M, Popov V, Smith MF, Welch BL, Wojcik R IEEE Transactions on Nuclear Science 2005 Jun 52 638-644 -
Potential applications of conventional and molecular imaging to biodefense research
Li K, Thomasson D, Ketai L, Contag C, Pomper M, Wright M, Bray M Clinical Infectious Diseases 2005 May 40 1471-1480 -
A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia
Sacktor N, Skolasky RL, Ernst T, Mao X, Selnes O, Pomper MG, Chang L, Zhong K, Shungu DC, Marder K, Shibata D, Schifitto G, Bobo L, Barker PB, Phil D Journal of Magnetic Resonance Imaging 2005 Apr 21 325-333 -
Translational molecular imaging for cancer.
Pomper MG Cancer Imaging 2005 5 Spec No A S16-26 -
Imaging bacterial infections with radiolabeled 1-(2′-deoxy-2′- fluoro-β-D-arabinofuranosyl)-5-iodouracil
Bettegowda C, Foss CA, Cheong I, Wang Y, Diaz L, Agrawal N, Fox J, Dick J, Dang LH, Zhou S, Kinzler KW, Vogelstein B, Pomper MG Proceedings of the National Academy of Sciences of the United States of America 2005 Jan 102 1145-1150 -
Synthesis and biodistribution of radiolabeled α7 nicotinic acetylcholine receptor ligands
Pomper MG, Phillips E, Fan H, McCarthy DJ, Keith RA, Gordon JC, Scheffel U, Dannals RF, Musachio JL Journal of Nuclear Medicine 2005 46 326-334 -
A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation
Lin KS, Luu A, Baidoo KE, Hashemzadeh-Gargari H, Chen MK, Brenneman K, Pili R, Pomper M, Carducci MA, Wagner HN Bioconjugate Chemistry 2005 16 43-50 -
Chordoid glioma of the third ventricle
Gallia GL, Pomper MG, Olivi A 2005 218-221 -
Small animal imaging in drug development
Pomper MG, Lee JS Current Pharmaceutical Design 2005 11 3247-3272 -
Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy
Dubey P, Fatemi A, Barker PB, Degaonkar M, Troeger M, Zackowski K, Bastian A, Smith SA, Pomper MG, Moser HW, Raymond GV Neurology 2005 Jan 64 304-310 -
Characteristic MR imaging changes in severe hypermethioninemic states [1]
Braverman NE, Mudd SH, Barker PB, Pomper MG American Journal of Neuroradiology 2005 26 2705-2706 -
Advanced cancers: Eradication in all cases using 3-bromopyruvate therapy to deplete ATP
Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, Hullihen J, Pedersen PL Biochemical and Biophysical Research Communications 2004 Nov 324 269-275 -
Bacteriolytic therapy can generate a potent immune response against experimental tumors
Agrawal N, Bettegowda C, Cheong I, Geschwind JF, Drake CG, Hipkiss EL, Tatsumi M, Dang LH, Diaz LA, Pomper M, Abusedera M, Wahl RL, Kinzler KW, Zhou S, Huso DL, Vogelstein B Proceedings of the National Academy of Sciences of the United States of America 2004 Oct 101 15172-15177 -
PET imaging of GRP receptor expression in prostate cancer
Scheffel U, Pomper MG Journal of Nuclear Medicine 2004 Aug 45 1277-1278 -
A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier
Lin KS, Luu A, Baidoo KE, Hashemzadeh-Gargari H, Chen MK, Pili R, Pomper M, Carducci M, Wagner HN Bioconjugate Chemistry 2004 15 1416-1423 -
Positron emission tomography in molecular imaging
Pomper MG, Hammoud DA IEEE Engineering in Medicine and Biology Magazine 2004 23 28-37 -
Dual low profile detector heads for a restraint free small animal SPECT imaging system
Weisenberger AG, Baba JS, Kross B, Gleason SS, Goddard J, Majewski S, Meikle SR, Paulus MJ, Pomper MG, Popov V, Smith MF, Welch BL, Wojcik R IEEE Nuclear Science Symposium Conference Record 2004 4 2456-2460 -
Metabolites in ventrilcular cerebrospinal fluid detected by proton magnetic resonance spectroscopic imaging
Nagae-Poetscher LM, McMahon M, Braverman N, Lawrie WT, Fatemi A, Degaonkar M, Horská A, Pomper MG, Chacko VP, Barker PB Journal of Magnetic Resonance Imaging 2004 20 496-500 -
Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria
Bettegowda C, Dang LH, Abrams R, Huso DL, Dillehay L, Cheong I, Agrawal N, Borzillary S, McCaffery JM, Watson EL, Lin KS, Bunz F, Baidoo K, Pomper MG, Kinzler KW, Vogelstein B, Zhou S Proceedings of the National Academy of Sciences of the United States of America 2003 Dec 100 15083-15088 -
The surgical bed after BCNU polymer wafer placement for recurrent glioma: Serial assessment on CT and MR imaging
Hammoud DA, Belden CJ, Ho AC, Dal Pan GJ, Herskovits EH, Hilt DC, Brem H, Pomper MG American Journal of Roentgenology 2003 May 180 1469-1475 -
Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging
Ouwerkerk R, Bleich KB, Gillen JS, Pomper MG, Bottomley PA RADIOLOGY 2003 May 227 529-537 -
Infantile hypermethioninemia and hyperhomocysteinemia due to high methionine intake: A diagnostic trap
Mudd SH, Braverman N, Pomper M, Tezcan K, Kronick J, Jayakar P, Garganta C, Ampola MG, Levy HL, McCandless SE, Wiltse H, Stabler SP, Allen RH, Wagner C, Borschel MW Molecular genetics and metabolism 2003 May 79 6-16 -
Development and testing of a restraint free small animal SPECT imaging system with infrared based motion tracking
Weisenberger AG, Kross B, Gleason SS, Goddard J, Majewski S, Meikle SR, Paulus MJ, Pomper M, Popov V, Smith MF, Welch BL, Wojcik R IEEE Nuclear Science Symposium Conference Record 2003 3 2090-2094 -
Spinal meningioma causing diffuse leptomeningeal enhancement
Lucey BP, Tihan T, Pomper MG, Olivi A, Laterra J Neurology 2003 Jan 60 350-351 -
Predicting the success of a radiopharmaceutical for in vivo imaging of central nervous system neuroreceptor systems
Wong DF, Pomper MG Molecular Imaging and Biology 2003 5 350-362 -
11C-MCG: Synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase)
Pomper MG, Musachio JL, Zhang J, Scheffel U, Zhou Y, Hilton J, Maini A, Dannals RF, Wong DF, Kozikowski AP Molecular Imaging 2002 Apr 1 96-101 -
Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine β-synthase (CBS) deficiency
Yaghmai R, Kashani AH, Geraghty MT, Okoh J, Pomper M, Tangerman A, Wagner C, Stabler SP, Allen RH, Harvey Mudd S, Braverman N American Journal of Medical Genetics 2002 Feb 108 57-63 -
Radiosynthesis of [11C]paclitaxel
Ravert HT, Klecker RW, Collins JM, Mathews WB, Pomper MG, Wahl RL, Dannals RF Journal of Labelled Compounds and Radiopharmaceuticals 2002 45 471-477 -
Can small animal imaging accelerate drug development?
Pomper MG Journal of Cellular Biochemistry 2002 211-220 -
Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: Correlation with [11C-methyl]thymidine pet and thallium-201 SPECT
Pomper MG, Constantinides CD, Barker PB, Bizzi A, Dobgan AS, Yokoi F, McArthur JC, Wong DF Academic radiology 2002 9 398-409 -
Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging
Mori S, Frederiksen K, Van Zijl PC, Stieltjes B, Kraut MA, Solaiyappan M, Pomper MG Annals of Neurology 2002 51 377-380 -
Are T1- and T2-weighted spin-echo MR images sufficient for the diagnosis of central nervous system vasculitis? [1] (multiple letters)
Guermazi A, Wasserman BA, Pomper MG American Journal of Roentgenology 2002 179 273-274 -
Astroblastoma: Radiologic-pathologic correlation and distinction from ependymoma
Port JD, Brat DJ, Burger PC, Pomper MG American Journal of Neuroradiology 2002 23 243-247 -
Diffusion tensor MR imaging of the brain and white matter tractography
Melhem ER, Mori S, Mukundan G, Kraut MA, Pomper MG, Van Zijl PC American Journal of Roentgenology 2002 178 3-16 -
Central nervous system vasculitis as a complication of refractory dermatomyositis
Regan M, Haque U, Pomper M, Pardo C, Stone J Journal of Rheumatology 2001 28 207-211 -
Molecular imaging: An overview
Pomper MG Academic radiology 2001 8 1141-1153 -
New techniques in magnetic resonance imaging of brain tumors
Pomper MG, Port JD Neuroimaging Clinics of North America 2001 11 501-525 -
Chordoid glioma: A neoplasm unique to the hypothalamus and anterior third ventricle
Pomper MG, Passe TJ, Burger PC, Scheithauer BW, Brat DJ American Journal of Neuroradiology 2001 22 464-469 -
Original report: Reliability of normal findings on MR imaging for excluding the diagnosis of vasculitis of the central nervous system
Wasserman BA, Stone JH, Hellmann DB, Pomper MG American Journal of Roentgenology 2001 177 455-459 -
Positron emission tomography in the detection and management of sarcomatous transformation in neurofibromatosis
Solomon SB, Semih Dogan A, Nicol TL, Campbell JN, Pomper MG Clinical nuclear medicine 2001 26 525-528 -
Subacute diencephalic angioencephalopathy: Biopsy diagnosis and radiological features of a rare entity
Tihan T, Burger PC, Pomper M, Sanchez O, Ramzan M, Eberhart CG, Hansen C, Smith TW Clinical Neurology and Neurosurgery 2001 103 160-167 -
Human skeletal muscle: Sodium MR imaging and quantification - Potential applications in exercise and disease
Constantinides CD, Gillen JS, Boada FE, Pomper MG, Bottomley PA RADIOLOGY 2000 Aug 216 559-568 -
New techniques in MR imaging of brain tumors
Pomper MG, Port JD Magnetic resonance imaging clinics of North America 2000 8 691-713 -
Radiolabeled neuronal nitric oxide synthase inhibitors: Synthesis, in vivo evaluation, and primate PET studies
Pomper MG, Musachio JL, Scheffel U, Macdonald JE, McCarthy DJ, Reif DW, Villemagne VL, Yokoi F, Dannals RF, Wong DF Journal of Nuclear Medicine 2000 41 1417-1425 -
Quantification and minimization of magnetic susceptibility artifacts on GRE images
Port JD, Pomper MG Journal of computer assisted tomography 2000 24 958-964 -
CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography
Pomper MG, Miller TJ, Stone JH, Tidmore WC, Hellmann DB American Journal of Neuroradiology 1999 20 75-85 -
Histoplasmosis mimicking vasculitis of the central nervous system
Stone JH, Pomper MG, Hellmann DB Journal of Rheumatology 1998 Aug 25 1644-1648 -
Sensitivities of noninvasive tests for central nervous system vasculitis: A comparison of lumbar puncture, computed tomography, and magnetic resonance imaging
Stone JH, Pomper MG, Roubenoff R, Miller TJ, Hellmann DB Journal of Rheumatology 1994 21 1277-1282 -
Fluorine-substituted corticosteroids: Synthesis and evaluation as potential receptor-based imaging agents for positron emission tomography of the brain
Pomper MG, Kochanny MJ, Thieme AM, Carlson KE, Vanbrocklin HF, Mathias CJ, Welch MJ, Katzenellenbogen JA International Journal of Radiation Applications and Instrumentation. 1992 May 19 461-480 -
Preparation and evaluation of 17-ethynyl-substituted 16α-[18F]fluoroestradiols: Selective receptor-based PET imaging agents
Vanbrocklin HF, Pomper MG, Carlson KE, Welch MJ, Katzenellenbogen JA International Journal of Radiation Applications and Instrumentation. 1992 Apr 19 363-374 -
Preparation and evaluation of 17-ethynyl-substituted 16α-[18F]fluoroestradiols: Selective receptor-based PET imaging agents
Vanbrocklin HF, Pomper MG, Carlson KE, Welch MJ, Katzenellenbogen JA International Journal of Radiation Applications and Instrumentation. 1992 Apr 19 363-374 -
Erratum: Preparation and evaluation of 17-ethynyl-substituted 16α-[18F]fluoroestradiols: selective receptor-based PET imaging agents (Nuclear Medicine and Biology - International Journal of Radiation Applications and instrumentation Part B (Vol.nr. 19) (363-374))
VanBrocklin HF, Pomper MG, Carlson KE, Welch MJ, Katzenellenbogen JA Nuclear Medicine and Biology 1992 19 I -
Assessment of 21-[18F]fluoro-16α-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas
Dehdashti F, McGuire AH, Van Brocklin HF, Siegel BA, Andriole DP, Griffeth LK, Pomper MG, Katzenellenbogen JA, Welch MJ Journal of Nuclear Medicine 1991 32 1532-1537 -
Fluorine-18 labeled estrogens: Synthesis and biological evaluation of 11β and 17α substituted estradiols
VanBrocklin HF, Welch MJ, Brodack JW, Mathias CJ, Pomper MG, Carlson KE, Katzenellenbogen JA Journal of Labelled Compounds and Radiopharmaceuticals 1991 30 427-429 -
Imaging agents for brain corticosteroid receptors: Synthesis and tissue distribution of 21-[18F]fluoro-deacylcortivazol
Kochanny MJ, Pomper MG, Carlson KE, Mathias CJ, VanBrocklin HF, Welch MJ, Katzenellebogen JA Journal of Labelled Compounds and Radiopharmaceuticals 1991 30 241-243 -
11β-Methoxy-, 11β-Ethyl- and 17α-Ethynyl-Substituted 16α-Fluoroestradiols: Receptor-Based Imaging Agents with Enhanced Uptake Efficiency and Selectivit
Pomper MG, Thieme AM, Thomas RD, Kiesewetter DO, Carlson KE, VanBrocklin H, Mathias CJ, Welch MJ, Katzenellenbogen JA Journal of Medicinal Chemistry 1990 Dec 33 3143-3155 -
Target tissue uptake selectivity of three fluorine-substituted progestins: Potential imaging agents for receptor-positive breast tumors
Pomper MG, Pinney KG, Carlson KE, Van Brocklin H, Mathias CJ, Welch MJ, Katzenellenbogen JA International Journal of Radiation Applications and Instrumentation. 1990 17 309-319 -
21-[18F]Fluoro-16α-ethyl-19-norprogesterone: Synthesis and Target Tissue Selective Uptake of a Progestin Receptor Based Radiotracer for Positron Emission Tomography
Pomper MG, Katzenellenbogen JA, Welch MJ, Brodack JW, Mathias CJ Journal of Medicinal Chemistry 1988 Jul 31 1360-1363 -
Uptake of three [3H]progestins by target tissues in vivo: Implications for the design of diagnostic imaging agents
Carlson KE, Brandes SJ, Pomper MG, Katzenellenbogen JA International Journal of Radiation Applications and Instrumentation. 1988 15 403-408
-
Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer